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Ribosomes form the core of the protein biosynthesis machinery and are essential to 
life. Ribosome biogenesis is a complex cellular process involving transcription of rRNA, 
pre-rRNA processing, rRNA modification and simultaneous assembly of ribosomal 
proteins. RNA nucleotide modification is observed in all domains of life. While there is 
enormous conservation of ribosome structure, very few post-transcriptional rRNA 
modifications have been conserved throughout evolution. A notable example of such rare 
conservation is the dimethylation of two adjacent adenosines in the 3’-terminal helix, a 
highly conserved region of the small subunit rRNA. Enzymes that carry out these 
 xii 
dimethylations are equally conserved and are collectively known as the KsgA/Dim1 family 
of methyltransferases. 
The first member of the family, KsgA, was identified in E. coli as the determinant 
for resistance to the aminoglycoside antibiotic Kasugamycin. Orthologs have since been 
described in organisms of wide spread evolutionary origins as well as in eukaryotic cellular 
organelles, thus underscoring the unprecedented conservation of this family of enzymes 
and the resultant rRNA modification. The higher evolutionary orthologs of KsgA have 
adopted secondary roles in ribosome biogenesis in addition to their dimethyltransferase 
role. The eukaryotic ortholog, Dim1, is essential for proper processing of the primary 
rRNA transcript. Recently, KsgA has been speculated to function as a late stage ribosome 
biogenesis factor and a ∆ksgA genotype in E. coli has been linked to cold sensitivity and 
altered ribosomal profiles. 
This report focuses on the biochemical characterization of KsgA and its interaction 
with the 30S subunit. We have established the salt conditions required for optimal KsgA 
methyltransferase activity while confirming that KsgA recognizes a translationally inactive 
conformation of 30S subunit in vitro. Our study of the functional conservation of 
KsgA/Dim1 enzymes in the bacterial system revealed that KsgA and the evolutionarily 
higher orthologs could recognize a common ribosomal substrate. This indicates that the 
recognition elements of both, the protein and the small subunit, have remained largely 
unchanged during the course of evolution. Finally, based on our site directed mutagenesis 
and biochemical studies, we report that KsgA binds to structural components of 16S rRNA 
other than the helix containing the target nucleosides. 
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CHAPTER 1: Introduction 
 
 
Ribosome biogenesis 
 
The ribosome is a universal complex enzyme essential to life. Ribosomes form 
the core of the protein biosynthesis machinery which manufactures proteins based on the 
genetically encoded messages. Since this discovery nearly five decades ago, the 
biogenetic, biophysical and functional aspects of the ribosome have become subjects of 
intensive research. For decades, microbial ribosomes have been exploited therapeutically 
as proven targets for anti-microbial agents1. The work reported in this dissertation 
focuses on a universally conserved ribosomal RNA modification and the equally 
conserved family of proteins responsible for the modification.  
Under favorable growth conditions, a single cell of Escherichia coli can contain 
up to 100,000 ribosome copies; accounting for nearly 40% of the dried cell mass2, 3. 
Ribosomes consist of two unequal subunits; a large subunit (50S/60S) and a small 
subunit (30S/40S) in prokaryotes/eukaryotes, respectively. Each subunit is composed of 
~65% ribosomal RNA (rRNA) and ~35% ribosomal proteins. Ribosome biogenesis, the 
process by which ribosomes are synthesized, is a fundamental cellular process involving 
transcription of rRNA, pre-rRNA processing, rRNA modification and simultaneous 
assembly of ribosomal proteins4. The process demands a high level of regulation, 
coordination and energy expenditure. It is estimated that a proliferating cell devotes more 
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than 50% of its cellular energy for the process of ribosomal synthesis, processing, and 
assembly2. 
Much of our understanding of the process of ribosome biogenesis in prokaryotes 
comes from years of work on E. coli5-8. The pre-16S rRNA undergoes multiple 
processing and maturation steps as it is transcribed, to give mature 16S rRNA9. Several 
non-ribosomal factors, including RNases are involved in this process. Based upon many 
observations, it is thought that 30S subunit assembly occurs co-transcriptionally or during 
16S rRNA maturation, and that the modification of nucleotides within 16S rRNA occurs 
concurrently with the process of 30S subunit assembly. However, the order of processing 
and subunit assembly events remains largely unknown. 
In vitro studies have contributed significantly to our understanding of ribosome 
biogenesis. A major milestone was achieved in 1968, when Traub and Nomura 
demonstrated that functional ribosomal subunits could be reconstituted in vitro using only 
the component rRNAs and ribosomal proteins purified from E. coli5. Subsequent to this 
discovery, functional 30S subunits were also reconstituted using individually purified 
30S subunit proteins10, either in natural or recombinant form, and in vitro transcribed 16S 
rRNA11, 12, which lacked nucleotide modifications. These reconstituted subunits have the 
same sedimentation behavior as natural subunits. They also function in tRNA binding 
and polyphenylalanine synthesis studies, although with lesser activity than the natural 
ribosomes11-13. Neverthless, in vitro assembly remains an important achievement since it 
enabled biochemical studies that could not have been performed otherwise. 
  3 
Another major milestone that enhanced the biophysical study of ribosomes was 
the first high resolution crystal structure of ribosomal subunits, the small subunit from the 
eubacterium Thermus thermophilus14 and the large subunit from the archaeon Haloarcula 
marismortui15. These structures were followed by that of the large subunit from the 
mesophilic eubacterium Deinococcus radiodurans16 and that of the 70S ribosomes from 
T. thermophilus17 and E. coli18. Later, Selmer et al. solved the structure of T. 
thermophilus 70S ribosome complexed with mRNA and tRNA, showing that the 
ribosome is indeed a ribozyme19. These structures have contributed invaluably to our 
understanding of the structure and function of the ribosome. 
In vitro as well as in vivo experiments have demonstrated that 30S subunit 
assembly is highly cooperative involving sequential addition of proteins and 
conformational changes in the growing subunit9. In vitro assembly experiments have 
allowed construction of a bacterial 30S subunit assembly map (Figure 1), which shows 
that ribosomal proteins assemble cooperatively onto the pre-16S rRNA in a roughly 5’ to 
3’ order, indicating co-transcriptional assembly in vivo20. The 30S subunit can 
structurally be divided into three regions – body (5’ domain), platform (central domain) 
and head (3’ domain). The assembly map shows that the body is assembled first, 
followed by the platform, with the head forming last.  
The in vitro reconstitution of 30S subunit proceeds through two experimentally 
determined intermediates6 (Figure 2B). At low temperatures (0 ˚C to 15 ˚C), a particle is 
formed which sediments at 21S. This particle has been termed RI, for Reconstitution  
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Figure 1. Assembly of the 30S subunit. (A) Assembly map (B) Crystal structure of 30S 
subunit. The three domains of 30S are roughly delineated and labeled. This figure was 
rendered using Pymol from the coordinates generated by Wimberly et al. (PDB ID 
1J5E)14. 
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Figure 2. 30S assembly in E. coli. (A) In vivo assembly. The chaperon system brings 
about the conformational change from RI to RI*. (B) In vitro assembly. Heat can bring 
about the conformational change from RI to RI*. 
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Intermediate, and consists of 16S rRNA plus a subset of ribosomal proteins (S4-S9, S11-
S13, and S15-S20). Most of these proteins are components of the body and platform. 
Unimolecular conformational rearrangement of RI yields RI*, a more compact particle 
with sedimentation coefficient of 26S, yet identical to RI in composition. The RI to RI* 
transition is the rate limiting step in assembly and requires either heat (42 ˚C) or the 
presence of a DnaK chaperone system to overcome the activation energy barrier21 (Figure 
2A). Once RI* has been formed, the remaining ribosomal proteins readily assemble on, 
even at low temperatures. Intermediates analogous to RI have been seen in vivo in certain 
cold sensitive mutants22, indicating that the in vitro reconstitution truly resembles the 30S 
subunit assembly in vivo. 
Although prokaryotic and eukaryotic ribosomes share similar basic architecture, 
ribosome biogenesis in eukaryotes is much more complex than that in prokaryotes. More 
than 150 factors23, including snoRNPs, GTPases, helicase, nucleases, transport proteins, 
and chaperones are thought to be involved in eukaryotic ribosome biogenesis. Ribosome 
synthesis starts in the nucleolus, where most of the maturation also takes place. The next 
few steps take place in the nucleus, with the final steps being completed in the 
cytoplasm24, 25 (Figure 3). 35S rRNA undergoes processing and maturation to yield the 
component rRNAs of the eukaryotic ribosome. As the pre-35S rRNA is being transcribed 
in the nucleolus, several factors including U3 snoRNP, small subunit ribosomal proteins 
and non ribosomal factors associate with it to form a 90S particle26. These particles 
correspond to the terminal ‘knobs’ seen in Miller chromatin spreads, a technique that  
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Figure 3. Schematic representation of Eukaryotic ribosome assembly. The terminal 
‘knobs’ are shown as spheres on the transcribing rRNA.  
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allows observation of actively transcribing rDNA by electron microscopy27, 28. Next, the 
pre-rRNA undergoes cleavage at three sites to yield mostly complete pre-40S (small 
subunit) particle and a very immature pre-60S (large subunit) particle24. Both particles 
are then exported to the cytoplasm, where a few final modifications yield the mature 40S 
particle. The pre 60S maturation is much more complicated and requires several 
processing steps to yield mature 60S. The association of ribosomal proteins occurs 
throughout the process of maturation, but detailed assembly pathways are not known. 
Also, in vitro reconstitution of eukaryotic ribosomes solely from the component rRNAs 
and ribosomal proteins have not been achieved yet. 
Ribosomal assembly in the archaeal system is not very well understood. The 
ribosomal protein composition is not the same in all archaeal organisms and depends on 
the phylogeny of the species29. Archaeal cells lack a nuclear membrane; however, at least 
one archaeal genome has been reported to contain putative homologs to nuclear and 
nucleolar structural genes from eukaryotes30, 31. Therefore, the possibility of spatio-
temporal control of ribosome synthesis cannot be totally discarded. In vitro, assembly of 
functional arcahaeal ribosomes from component rRNAs and ribosomal proteins occurs 
spontaneously; however, conditions reflecting the organism’s natural environment are 
required32-34. For example, thermophilic ribosomes require high temperatures34 whereas 
halophilic ribosomes require high salt concentrations35 for in vitro assembly. 
Nucleotide Modification 
RNA nucleotide modification is observed in all domains of life. Although the 
function of most rRNA nucleotide modifications remains unknown, the general view 
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holds that they serve to fine tune the ribosomal structure and function. Nucleotide 
modification occurs simultaneous to pre-rRNA processing and subunit assembly events 
in ribosome biogenesis. There are three major types of modifications in rRNA – 
conversion of uridine to pseudouridine, 2'-O-ribose methylation, and base methylations36 
(Figure 4). 
Modifications in bacteria are mainly base methylations and are performed by 
specific enzymes, one enzyme catalyzing only one modification in most cases37. 
Contrastingly, modifications in eukaryotic ribosomes are mainly pseudouridinylations 
and 2'-O-ribose methylations with only a few base methylations38. Also, in eukaryotic 
cells, similar modifications are carried out by a common enzyme, guided by snoRNAs to 
the specific location39. The archaeal rRNA modification is less well characterized, and 
there is a great deal of variation from species to species. Modifications are mostly 2'-O-
ribose methyls with only a few pseudouridines40. With snoRNAs guiding the 
modifications, the archaeal modification system appears to be more similar to that in 
eukaryotes41-43. 
The basic architecture of the ribosome has remained largely conserved throughout 
evolution44. The modified nucleotides are clustered within the conserved, functionally 
important regions of the ribosome45. However, no single rRNA modification has been 
reported to be essential for ribosome function. Collective blockade of pseudouridylations 
and 2'-O-methylations showed severe growth defects in Saccharomyces cerevisiae46. 
Similarly, eubacterial ribosomes reconstituted using in vitro 
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Figure 4. Nucleoside modifications. (A) Adenosine, (B) N6, N6-dimethyladenosine, 
(C) Cytidine, (D) 2’-O methylcytidine, (E) Uridine, (F) Pseudouridine 
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transcribed, unmodified rRNA show much less activity in peptide synthesis than 
ribosomes reconstituted from natural rRNA47-49. Thus, it seems that individual 
modifications are indeed involved in fine tuning of ribosome’s structure and function, 
offering a larger benefit, collectively.    
While there is enormous conservation of ribosome structure between the 
prokaryotic, archaeal and eukaryotic ribosomes, very few post-transcriptional rRNA 
modifications have been conserved throughout evolution. A notable example of such rare 
conservation is the dimethylation of two adjacent adenosines in the 3’-terminal helix of 
small subunit rRNA, A1518 and A1519 in helix 45 by E. coli numbering system (Figure 
5).  The only known exceptions are in Saccharomyces cerevisiae mitochondrial 12S 
rRNA, which has no methyl groups on the two adenosine bases50; Euglena gracilis 
chloroplast rRNA51 and the 16 S rRNA of the archaebacterium Sulfolobus solfataricus52, 
both of which have only one dimethylated adenosine base. The 3’-terminal helix, which 
is involved in linking the small subunit to the large subunit53 of the ribosome and in 
binding to mRNA54, is one of the most conserved regions of the small subunit55, 56. 
Enzymes that carry out the dimethylations in this highly conserved region are equally 
conserved and are collectively known as the KsgA/Dim1 family of methyltransferases, 
where KsgA is the bacterial ortholog and Dim1 is the eukaryotic ortholog. 
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Figure 5. Dimethyladenosines in the 16S rRNA of E. coli. (A) Secondary structure of the 
E. coli 16S rRNA. Helix 45, where the two dimethylated adenosines are located, is 
circled in red. (B) Helix 45. Stars indicate modified adenosines. 
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KsgA/Dim1 Family of Methyltransferases 
The presence and function of the KsgA/Dim1 family of enzymes have been 
maintained throughout all domains of life, including the eukaryotic cellular organelles. 
The enzyme was first described in E. coli, where it catalyzes the conversion of two 
adjacent adenosines A1518 and A1519, also conserved, in the 30S subunit rRNA to N6, 
N6-dimethyladenosines (Figure 6)57, 58. Orthologs have since been described in organisms 
of diverse origins including KsgA in the eubacteria Bacillus stearothermophilus59, Dim1 
in Saccharomyces cerevisiae60 and Kluyveromyces lactis61, and MjDim1 in the archaea 
Methanocaldococcus jannaschii62. Analogus methyltransferases, h-mtTFB and Pfc1, 
have been identified in the human mitochondria63 and in the chloroplasts of Arabidopsis 
thaliana64, respectively. Although KsgA/Dim1 from no other species has been tested, the 
wide spread evolutionary origins of the above members underscore the unprecedented 
conservation of this family of enzymes and the resultant rRNA modification. 
KsgA (Figure 8A) is dispensable in bacteria with only modest consequences and 
forms the dominant mode by which bacteria become resistant to the aminoglycoside 
antibiotic kasugamycin57, 65. A KsgA knockout mutant lacks the dimethyls on 
A1518/A1519 and shows slower growth rate in Escherichia coli and reduced virulence in 
the human pathogen, Yersina pseudotuberculosis66-68. Recently, KsgA has been 
speculated to function as a late stage ribosome biogenesis factor69.  
The higher evolutionary members of this family have adopted secondary roles in 
ribosome biogenesis in addition to their dimethyltransferase role. Eukaryotic Dim1  
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Figure 6.  Conversion of adenosine to N6, N6-dimethyladenosine catalyzed by the 
KsgA/Dim1 family of methyltransferases. Two molecules of SAM are consumed per 
adenosine. 
 
S-Adenosyl-L-Methionine
(SAM)
S-Adenosyl-Homocysteine
(SAH)
KsgA / Dim1
family
N
N
N
N
N
O
OHO
HH
HH
O
CH3H3C
  15 
(Figure 8B) is a member of the processome and is essential for proper processing of the 
primary rRNA transcript70. Knockout of Dim1 in yeast is lethal60; loss of Dim1 in S. 
cerevisiae leads to depletion of 18S rRNA and buildup of an aberrant 22S rRNA species 
as a result of misprocessing70. Pfc1, the chloroplast ortholog, has been found to be 
important for proper development of chloroplasts at low temperatures64. Depletion of 
Pfc1 results in accumulation of misprocessed rRNA, suggesting a role similar to Dim1. 
The human mitochondrial ortholog h-mtTFB was originally demonstrated to be a 
mitochondrial transcription factor71. h-mtTFB has also been linked to hereditary deafness 
associated with a polymorphic A1555G mutation in mitochondrial rRNA72. In some 
mitochondria, there are two separate mtTFB proteins, mtTFB1 and mtTFB2, which are 
proposed to have arisen from a gene duplication event73. As per the evidence, mtTFB1 is 
more active as a methyltransferase, while mtTFB2 is more active as a transcription 
factor73, 74. The fungi have only a single mtTFB, suggesting loss of one of the paralogs in 
this lineage. The S. cerevisiae ortholog, sc-mtTFB, serves as a transcription factor but has 
completely lost its methyltransferase activity50. sc-mtTFB lacks significant sequence 
homology to any of the KsgA/Dim1 enzymes and yeast mtTFBs are poorly conserved 
and difficult to identify via sequence homology75. 
Dim1 of S. cerevisiae and h-mtTFB have been shown to dimethylate A1518 and 
A1519 of E. coli 30S in vivo63, 76. However, similar experiments by Pulicherla et al. to 
test for complementarity of archaeal Dim1 and bacterial KsgA in S. cerevisiae revealed 
that neither the bacterial nor the archaeal ortholog could complement for the eukaryotic 
Dim177. This might be related to the secondary, non-methyltransferase function that 
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Dim1 is known to play in eukaryotic ribosome biogenesis.  In the cases of both Dim1 and 
h-mtTFB, the methylating activity is separate from the second function; methylation-
deficient mutations can be made, which leave the rRNA processing or transcription 
activity intact76, 78. Pulicherla et al. also confirmed that in S. cerevisiae, none of the 
methyl groups transferred by Dim1 are critical for growth under standard conditions and 
a variety of temperatures77.  
The Erm family of methyltransferases, which confers resistance to the macrolide-
lincosamide-streptogramin B (MLS-B) group of antibiotics, are important paralogs of the 
KsgA/Dim1family79. These enzymes share high sequence homology with the KsgA 
family80 and have most likely resulted from one or more KsgA gene duplication events81. 
The Erm enzymes transfer one or two methyl groups to a single adenosine of 23S rRNA, 
near the peptidyl transferase site of the 50S subunit79.  
The KsgA/Dim1 family belongs to a well-characterized group of S-adenosyl-L-
methionine (SAM) dependent methyltransferases which includes RNA 
methyltransferases, DNA methyltransferases, protein methyltransferases and small 
molecule methyltransferases. Many of these enzymes have been well characterized 
structurally and biochemically. Enzymes of this group contain a Rossman-like fold, 
which consists of a central β-sheet surrounded by a variable number of α-helices, with 
well-defined SAM and target nucleotide binding pockets82. Thus, the methyltransferase 
function of the KsgA/Dim1 enzymes had a clear structural basis, but the structural basis 
for other functions remained unclear for years. Recently O'Farrell et al. carried out 
extensive sequence alignments and structural comparisons of the KsgA, Dim1, sc-mtTFB 
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Figure 7. Sequence alignment of KsgA, Dim1, ErmC', h-mtTFB, and sc-mtTFB 
(GenBank accession nos. P06992, P41819, P13956, NP_057104, and P14908). Red 
letters designate residues that are absolutely conserved in KsgA enzymes, while green 
letters designate residues that are highly conserved. Figure adopted from elsewhere84.  
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Figure 8. Crystal structures of (A) KsgA (PDB ID: 1QYR)84(B) Dim1 (PDB ID: 1ZQ9; 
Dong, A.; Wu, H.; Zeng, H.; Loppnau, P.; Sundstorm, M.; Arrowsmith, C.; Edwards, A.; 
Bochkarev, A.; Plotnikov, A., unpublished data) (C) ErmC' (PDB ID: 1QAM)85 All 
figures were generated using program Pymol. 
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and ErmC' enzymes and identified regions that are likely related to functions other than 
the common methyltransferase function (Figures 7 and 8)83. They reported that core 
regions common to the entire class of enzymes are associated with ribosome binding and 
therefore the rRNA methylation activity, whereas regions conserved in the subgroups are 
related to the non-methyltransferase functions. 
KsgA 
The ksgA gene was first described by Dahlberg et al. in 1971 as a locus that 
affected methylation in the 16S rRNA and determined resistance to the aminoglycoside 
antibiotic kasugamycin (ksg)57. 16S rRNA from the resistant mutant lacked dimethylation 
of two adenosines, A1518 and A1519, on the 3’ terminal helix. Therefore, the ksgA locus 
was proposed to encode an rRNA methyltransferase. This was found to be true when an 
rRNA methylase activity, absent in the ksg resistant strains, was characterized in ksg 
sensitive strains. This methylase activity was also shown to alter the phenotype of ksg 
resistance by dimethylating in vitro the two adenosines in the 16S rRNA of resistant 30S 
subunits65. The methylase activity was later attributed to KsgA (Figure 8A), the product 
of ksgA gene. In the following decades KsgA has received intermittent scrutiny, 
uncovering facts about KsgA and its orthologs.  
Although KsgA is universally conserved, it is startling that KsgA knockout is 
tolerated in bacteria with only modest consequences. Igarishi et al. described a 
kasugamycin resistant strain which grew slower than the wild type strain on certain 
culture media66. Also, the ribosomes from the resistant strain showed slower polypeptide 
synthesis in the in vitro assays than wild-type ribosomes. However, in this case, the 
translational impairment was not directly a result of the undermethylation of 16S rRNA. 
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The loss of modification likely affected the subunit assembly since ribosomes from the 
resistant strain were found to contain lower amounts of ribosomal protein S1 than those 
from the wild-type strain. S1 is essential for normal translation in E. coli86; ribosomes 
lacking the S1 protein cannot translate mRNA containing leader sequences, but are able 
to translate leaderless mRNAs87. This probably was the reason for slower polypeptide 
synthesis.  
van Buul et al. described a ksgA mutant strain which displayed ribosomal 
ambiguity in in vitro translation assays67. Ribosomes purified from the mutant strain 
allowed leakiness of nonsense and frameshift mutations in in vitro translation assays. 
Although protein composition of the mutant 30S was not analyzed, given the proximity 
of the adenosines to the functional center of the ribosome, it seems likely that the 
presence or absence of the methyl groups could have a direct effect on translational 
fidelity. The loss of KsgA function has been shown to reduce virulence in at least one 
human pathogen, Yersina pseudotuberculosis68.  
Although the importance of the methyl groups for proper ribosome function was 
evident from the above works, the exact role and thus the reason for universal 
conservation of KsgA and the result modification remained largely elusive. Given the 
range of functions displayed by KsgA orthologs, it was speculated that KsgA may play a 
larger role in ribosome biogenesis, beyond methylation. This possibility was pointed at 
when Inouye et al. discovered a functional link between KsgA and Era88-90. They isolated 
a cold-sensitive Era mutation which resulted in defects in cell division and in rRNA 
processing. The cold-sensitive phenotype of this mutant was complemented by 
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overexpression of KsgA, hinting thereby that KsgA may have a role in ribosome 
assembly similar to that of Era, RbfA, RimM, RimN, and RsgA.  
Connolly et al. recently offered a mechanistic explanation for the extreme 
conservation of the KsgA/Dim1 family of enzymes69. They propose that KsgA functions 
as a late stage ribosome biogenesis factor and that the methylation triggers release of 
KsgA from the assembling subunit, allowing it to finally mature and enter the translation 
cycle with the speculation that it functions as a gatekeeper. Connolly et al. also reported 
that a ∆ksgA genotype in E. coli is linked to cold sensitivity and altered ribosomal 
profiles, and that a methyltransferase-inactive form of KsgA is profoundly deleterious to 
cell growth and ribosome biogenesis69. The binding site of KsgA on the 30S ribosomal 
subunit is thought to overlap with that of IF3 binding site and 50S subunit association 
sites91. Xu et al. observed that addition of IF3 lead to a loss of directed cleavage of 16S 
rRNA by KsgA in their hydroxyl radical probing experiments91. This again indicates that 
KsgA might function as a gatekeeper, occluding these translational components from 
binding until an ‘appropriate’ assembly of structurally and functionally competent 30S 
subunit has occurred91. 
KsgA transfers methyl groups from four molecules of SAM to two adenosines in 
the 16S rRNA (Figure 6). However, the exact mechanism of methyl group transfer 
remains to be elucidated. There is no data concerning the number of binding events 
required to transfer four methyl groups or the order in which the methyl groups are 
transferred by KsgA to the two adenosines. In case of ErmC', there is strong evidence that 
dimethylation of the target adenosine occurs in two separate events92. Here, the enzyme 
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dissociates after transferring one methyl group and transfers the other in a second binding 
event. It has been reported that, under stringent conditions (low SAM concentration and 
low temperature), KsgA preferentially dimethylates the 3' proximal adenosine, suggesting 
some preference for ordered methylation51. However, if either adenosine is mutated the 
other is still able to be methylated, indicating that any such preference is not obligatory93. 
Substrate requirements for KsgA 
So far, KsgA is the only rRNA post-transcriptional modification enzyme known 
to be conserved in all three domain of life as well as in eukaryotic cellular organelles59-61, 
63, 64
. The KsgA/Dim1 family bears sequence and structural semblance to a large group of 
S-adenosyl-L-methionine (SAM) dependent methyltransferases. ErmC' (Figure 8C), the 
rRNA methyltransferase involved in macrolide resistance80 is an important paralog of 
KsgA. KsgA and ErmC' are closely related structurally and catalyze very similar 
reactions. However, substrate recognition by KsgA is subject to complex regulation that 
is absent from the Erm methyltransferases84.  
ErmC' can bind and methylate a 32 nucleotide RNA fragment containing the 
target adenosine94. KsgA has also been shown to bind a small RNA fragment that 
contains the target adenosines, but it is unable to methylate the fragment or even naked 
16S95. KsgA remains enzymatically inactive until a partially matured small subunit has 
assembled96. The reason behind this remains unclear. One possible explanation is that 
KsgA is regulated allosterically; free KsgA could exist in a conformation that is 
competent for rRNA binding but not methylation. This hypothesis is supported by the 
observations that free KsgA does not bind SAM appreciably58, and that in the crystal 
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structure of KsgA, the active site pocket is not large enough to accommodate two 
adenosine bases simultaneously84. Therefore, a second interaction, beyond the site of 
modification, between KsgA and its pre-30S substrate may be required for KsgA 
activation84.  
It is possible that in vivo KsgA binds to an early intermediate 16S rRNA, but only 
when the correct pre-30S particle is assembled, does the interaction trigger binding of 
SAM to KsgA and also positions the target rRNA in such a way that the two nucleotides 
flip into the active site successively. Dim1 and h-mtTFB have been shown to complement 
for KsgA function in bacteria60, 63. This indicates that the bacterial, eukaryotic, and 
organellar enzymes can recognize a common bacterial substrate, despite differences in 
the respective 30S maturation processes. We have extended the previous 
complementation studies to include an archaeal ortholog MjDim1 from the organism, M. 
jannaschii and have examined the activity of MjDim1 and Dim1 from S. cerevisiae 
(ScDim1) both in vivo and in vitro in bacterial systems (Chapter 3). 
The composition of the true in vivo substrate for KsgA remains to be identified, 
but the study by Thammana and Held showed that in vitro, the minimal substrate requires 
16S rRNA plus the ribosomal proteins S4, S6, S8, S11, S15, S16, S17, and S18, all part 
of the RI (21S) particle (Figure 9)96. However, the same study reported that subsequent 
addition of the proteins S3, S9, S10, S14, and S21 is refractory to KsgA activity, 
suggesting that dimethylation of A1518 and A1519 occurs during a specific point during 
ribosome assembly. According to Thammana and Held, fully formed 30S complexes are  
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Figure 9. 30S ribosomal proteins required for and refractory to KsgA activity, according 
to Thammana and Held96. In light gray ribbon is 16S rRNA except for A1518 and A1519 
of helix 45, which are yellow and blue, respectively, and in space-filling representation. 
In green ribbon are those proteins necessary for KsgA activity. In red ribbon are those 
proteins that are refractory to KsgA activity. The remaining ribosomal proteins are in 
dark gray ribbon. The three domains of 30S are roughly delineated and labeled. This 
figure was rendered using Pymol from the coordinates generated by Wimberly et al. 
(PDB ID 1J5E)14. 
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not competent methylation substrates for the same reason. Curiously, a reevaluation of 
the inhibitory proteins by Poldermans et al.58 concluded that only S21 is inhibitory to 
KsgA activity. They further concluded that the Thammana and Held96 observations were 
the results of S21 and/or IF3 (also inhibitory to KsgA) impurities in their ribosomal RNA 
stocks. Also, in vivo stalled RI (21S) intermediates apparently are not methylated at 
A1518 and A15197, which suggests that methylation occurs when RI* (26S) forms or 
later. 
Direct comparison between the results obtained by the two groups is problematic 
because the methylation reactions performed contained different concentrations of Mg2+ 
and NH4+. This is an important consideration because the conformational state of the 30S 
subunit is sensitive to the concentrations of monovalent and divalent cations97, 98. We 
have resolved this issue by assaying KsgA under different concentrations of monovalent 
and divalent cations (Chapter 2). We also report that, in vitro, KsgA does not recognize 
the assembly intermediate RI (21S) as a substrate, meaning that methylation occurs after 
RI (21S) has been formed. 
Apart from regulation for substrate recognition, KsgA must also be subject to 
complex temporal regulation. Ten bases are methylated in E. coli 16S rRNA and out of 
them six, including A15181 and A1519, are clustered in the same immediate area. 
m2G1516 is located in the loop of helix 45, very close to A15181 and A1519; 
m4Cm1402, m5C1407 and m3U1498 are located at the base of helix 44. During the 
window of time between KsgA binding and release, at least two other methyltransferases 
are thought to bind their respective target sites, which must overlap with that of KsgA 
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binding site since the bases are clustered. Therefore, these processing events must require 
exquisite timing to ensure that the modifications are carried out correctly without the 
various enzymes interfering with one another. 
Substrate binding to KsgA 
In order to gain complete insight into the role of KsgA in ribosome biogenesis and 
how it interacts with other ribosome biogenesis factors or chaperons, it is extremely 
important to determine the binding site of KsgA on the 30S subunit. However, there 
seems to be a great deal of incongruity in the literature regarding this information. 
Initially, based on the inspection of crystal structure of KsgA, mutagenesis data of ErmC' 
and assumed correspondence with DNA methyltransferases, KsgA was thought to bind 
helix 45 along the cleft formed between its N- and C- terminal domains84. However, 
questions remained regarding this mode of binding since the KsgA crystal structure 
showed that the active site pocket was not large enough to accommodate two adenosine 
bases simultaneously, which would most likely be required for this mode of binding. 
Crystal structure of KsgA in complex with 30S subunit, which would possibly answer 
these questions, has remained unachievable for years. 
Xu et al. proposed a model of KsgA-16S rRNA complex based on hydroxyl 
radical probing and footprinting data 91. Their model positions KsgA such that its N-
terminal interacts with the 790 loop of 16S rRNA and almost the entire protein interacts 
with the top portion of helix 44 in a linear fashion. This arrangement puts the target 
adenosines of helix 45 within close proximity to the active site of KsgA (motif VIII)84, 
but KsgA never binds helix 45.  
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On the other hand, Tu et al. recently reported the crystal structure of Aquifex 
aeolicus KsgA bound to double stranded RNA via the cleft between its N- and C-terminal 
domains99. The RNA used in their study represents the helix 45 of E. coli 16S rRNA. 
Helix 45, according to the structure of E. coli 30S subunit18, forms a hairpin structure 
capped by a tetraloop that contains the target adenosines methylated by KsgA. However, 
the KsgA-RNA crystal structure reported by this group shows a duplex formed by the 
association of two RNA molecules instead of a hairpin formed by a single RNA 
molecule. This unnatural form of RNA leaves room for skepticism on whether KsgA 
truly binds helix 45 in vivo.  Moreover, the mode by which KsgA interacts with 16S 
rRNA is also different as per the above two reports. The different binding modes require 
dramatically different mechanistic details of KsgA. We have examined the key 16S 
rRNA sites implicated in binding to KsgA using site directed mutagenesis and in vitro 
methods (Chapter 4).  
Objectives 
 
KsgA and its orthologs represent a universally conserved family of RNA 
methyltransferases and have been shown to play an integral role in the biogenesis of 
functional ribosomes. The crystal structure of E. coli KsgA84 had been solved in our 
laboratory at the onset of this project. Though the crystal structure greatly enhanced our 
understanding of the enzyme, several questions remained that demanded biochemical 
characterization of the protein as it associates with its substrate. The studies presented 
here were undertaken in order to better understand the biochemical and structural 
requirements for the optimal functioning of KsgA and to lay a foundation for future 
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investigations. In our first study, we established the salt conditions required for optimal 
KsgA methyltransferase activity while confirming that KsgA recognizes a translationally 
inactive form of 30S subunit in vitro. This information has enabled efficient in vitro 
assays for further characterization of KsgA/Dim1 enzymes.  
 Our study of the functional conservation of KsgA/Dim1 enzymes in the bacterial 
system revealed that KsgA and the evolutionarily higher orthologs could recognize a 
common ribosomal substrate. Since then, a similar complementation experiment in S. 
cerevisiae in our lab has shown that none of the orthologs could complement the 
eukaryotic Dim1, probably due to the non-conserved secondary, non-methyltransferase 
function77. 
 Finally, to characterize the interaction of KsgA with the 30S subunit, we carried 
out site-directed mutagenesis of 16S rRNA followed by biochemical analysis of purified 
mutant 30S subunits with KsgA. Our results support the KsgA-16S rRNA model recently 
proposed by Xu et al.91  
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CHAPTER 2: Characterization of Substrate 
 
 
 
The KsgA/Dim1 family bears sequence and structural resemblance to a large 
group of S-adenosyl-L-methionine (SAM) dependent methyltransferases, one of which is 
ErmC', the rRNA methyltransferase involved in macrolide resistance80. KsgA and ErmC' 
are closely related structurally and both catalyze the transfer of two methyl groups from 
SAM to the target adenosines on rRNA. However, substrate recognition by KsgA is 
subject to complex regulation that is absent from the Erm methyltransferases84. ErmC' 
can bind and methylate a 32 nucleotide RNA fragment containing the target adenosine94. 
KsgA has also been shown to bind a small RNA fragment that contains the target 
adenosines, but it is unable to methylate that fragment or even naked 16S95. KsgA 
remains enzymatically inactive until a partially matured small subunit has assembled96. 
The reason behind this remains unclear.  
From the crystal structure of KsgA, it is clear that the active site pocket of KsgA 
is not large enough to accommodate two adenosine bases simultaneously84. Also, SAM 
binds KsgA very weakly until the enzyme interacts with fully or partially formed 30S 
subunits58. Therefore, a second interaction, beyond the site of modification, between 
KsgA and its pre-30S substrate may be required for KsgA activation84. It is possible that 
in vivo KsgA binds to an early intermediate 16S rRNA but, only when the correct pre-
30S particle is assembled, does the interaction trigger binding of SAM to KsgA and also 
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positions the target rRNA in such a way that the two nucleotides flip into the active site 
successively. 
The composition of the true in vivo substrate for KsgA remains to be identified, 
but the study by Thammana and Held showed that in vitro, the minimal substrate requires 
16S rRNA plus the ribosomal proteins S4, S6, S8, S11, S15, S16, S17, and S1896. 
However, the same study reported that subsequent addition of the proteins S3, S9, S10, 
S14, and S21 is refractory to KsgA activity, suggesting that dimethylation of A1518 and 
A1519 occurs during a specific point during ribosome assembly. Curiously, a 
reevaluation of the inhibitory proteins by Poldermans et al.58 concluded that only S21 is 
inhibitory to KsgA activity. They further concluded that the Thammana and Held 
observations96 were the results of S21 and/or IF3 (also inhibitory to KsgA) impurities in 
their ribosomal RNA stocks. 
Direct comparison between the results obtained by the two groups is problematic 
because the methylation reactions performed contained different concentrations of Mg2+ 
and NH4+. This is an important consideration because the conformational state of the 30S 
subunit is sensitive to the concentrations of monovalent and divalent cations97, 98. 
Thammana and Held used high concentrations of NH4+ and high Mg2+, which stabilize 
the conformation of 30S into an ‘active’ state. The active state is defined as the ability of 
30S subunits to support translation and integral translational functions such as binding 
tRNA and mRNA. The buffer used by Poldermans et al.58, which contained low NH4+ 
and intermediate Mg2+, was optimized to enhance methylation of 30S particles by KsgA. 
Traditionally, intermediate NH4+ and low Mg2+concentrations have been used to stabilize 
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30S in a translationally ‘inactive’ state. The buffer used by Poldermans et al. should still 
be able to trap the 30S in the inactive state. Despite the different reaction conditions, both 
groups observed that S21 is inhibitory to KsgA activity. It is possible that only S21 is 
truly inhibitory but the proteins S3, S9, S10 and S14 also become inhibitory at the 
elevated monovalent and divalent cation concentrations used by Thammana and Held. 
This chapter directly addresses KsgA activity as it relates to 30S conformation. We also 
report that, in vitro, KsgA does not recognize the assembly intermediate 21S as a 
substrate, meaning that methylation occurs after 21S has been formed. 
Recombinant KsgA is functional 
To confirm that the recombinant KsgA was active and that the 30S subunits 
isolated from a kasugamycin resistant E. coli strain were unmodified at positions A1518 
and A1519 of 16S rRNA, we performed methylation activity assays using our 
biochemical stocks and a published protocol (Figure 10)58. Recombinant KsgA is able to 
efficiently methylate 30S subunits isolated from strains of E. coli resistant to 
kasugamycin, but not wild-type 30S subunits, indicating that the methylation function is 
specific for A1518 and A1519. Had non-specific methylation taken place then both 30S 
types would have been modified by KsgA. 
KsgA recognizes 30S in an ‘inactive’ state 
Standard protocols to isolate 30S subunits from sucrose gradients trap them in an 
‘inactive’ state that require heat activation at 42 °C for 10min in the presence of 100mM 
NH4+ and 20mM Mg2+ prior to use in standard translation assays97. 30S subunits in very  
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Figure 10. Methylation of 30S by recombinant KsgA. All reactions were performed for 
30 min at 37 °C in Buffer I and contained 3H-SAM. 1, KsgA + 30S subunits from 
Kasugamycin-resistant E. coli strain ksgR11. 2, KsgA + 30S from wild-type E. coli. 3, 
KsgA without any 30S subunits. 4, 30S from ksgR11 without KsgA. 
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Figure 11. The effect of 30S conformation on KsgA activity. Standard activity assay in 
buffers K, A and I. Buffers K and I stabilize 30S subunits into a translationally inactive 
state while Buffer A stabilizes 30S subunits into the translationally active state. Error bars 
indicate plus and minus one standard deviation unit. 
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low NH4+ or low Mg2+ will never (or very slowly) convert to the active conformation as a 
result of the annealing step98. 
We directly compared conditions used by Thammana and Held (high NH4+ 
(200mM) and high Mg2+ (20mM) buffer), which traps 30S in the translationally active 
state with those used by Poldermans et al. (low NH4+ (40mM) and intermediate Mg2+ (4 
mM) buffer), which trap 30S in a translationally inactive state, along with conditions 
traditionally used to stabilize 30S into the translationally inactive state (intermediate 
NH4+ (100mM) and low Mg2+ (0.5 mM) buffer; Figure 11). Most striking is the fact that 
under cation concentrations that stabilize 30S subunits in the translationally active state 
(high NH4+ and high Mg2+) very little methylation occurs. In contrast, the two reaction 
conditions expected to hold 30S in an inactive state promote efficient methylation. Buffer 
K, which contains 4mM Mg2+, is the most active with regard to KsgA activity. 
Poldermans et al. previously reported that KsgA activity is maximal at 4mM Mg2+ when 
NH4+ concentration remained low58. The intermediate activity observed in Buffer I is 
probably the result of a Mg2+ concentration of only 0.5mM, which is below the optimal 
concentration for KsgA activity. It is important to stress that a concentration of only 
3mM Mg2+ is too low for 30S subunits to adopt the active conformation98. We do not 
know if KsgA has a direct Mg2+ requirement or if the suitability of 30S to serve as a 
substrate is altered when the Mg2+ concentration is changed from 0.5 to 4mM. 
Nevertheless, it is clear that KsgA is unable to utilize 30S subunits in the translationally 
active state as a substrate. 
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The above conclusions are supported by numerous structural data of 30S in the 
active and inactive conformations. In the crystal structure of the Thermus thermophilus 
30S subunit, which is a snapshot of 30S in the active conformation, A1518 and A1519 
are well buried into the groove of helix 44 and therefore sequestered from KsgA14. 
However, conversion to the inactive state exposes the same two nucleotides to the 
solvent100 through domain movements that involve the platform region of 30S101. The 
structure of the GGAA tetraloop in helix 45 in context of the crystal structure and free in 
solution are also different14, 102, which might also impact the reactivity of A1518 and 
A1519. 
Does KsgA recognize an assembly intermediate of 30S? 
Closer scrutiny of the proteins required for KsgA activity and those inhibitory to 
KsgA function argues that dimethylation of A1518 and A1519 occurs at an intermediate 
point during the assembly pathway of 30S. In vitro assembly of 30S is a highly 
cooperative process6, 103, 104. Early binding proteins, S4–S9, S11–S13, and S15–S20, 
assemble with 16S rRNA to form a relatively loose ribonucleoprotein particle with a 
sedimentation coefficient of the 21S particle. The remaining ribosomal proteins, S2, S3, 
S10, S14, S10, and S21, are unable to bind to 21S. However, heating 21S at 42 °C in 
vitro results in a change in 16S rRNA conformation that causes 21S to collapse into a 
denser particle of the same composition, but with a sedimentation value of 26S105. At this 
point the remaining ribosomal proteins readily bind to 26S, yielding active 30S. 
Thammana and Held reported that purified 16S rRNA plus a set of eight proteins (S4, S6, 
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S8, S11, S15-S18), all part of the 21S/26S particle, could serve as a minimal substrate for 
KsgA in vivo96.   
Although 21S and 26S particles were identified in vitro, counterparts are present 
in vivo 22, 106, 107. Based on the fact that the pre-30S assembly intermediates 21S and 26S 
both contain the eight proteins important to KsgA activity, one would predict that in vivo 
either the 21S or the 26S (or both) conformation is a substrate for KsgA. However, 
analysis of nuclease digests of in vivo pre-30S particles, which are analogous to the in 
vitro 21S particle, indicate that the dimethyladenosines are not yet present, which led the 
authors of that work to conclude that methylation at A1518 and A1519 had not yet 
occurred7. If KsgA recognizes a specific assembly state of 30S in vivo, then that 
assemblage appears to come after 21S has formed.  
The lack of methylation in the in vivo 21S particle presents a conundrum. The 
21S intermediate contains all eight ribosomal proteins shown to be essential for efficient 
methylation in vitro. On this basis we would expect 21S to be a viable substrate in vitro.  
Therefore, we asked if KsgA could methylate 21S particles generated by in vitro 
reconstitution. At 40 °C, reconstitution of 16S rRNA and total proteins of 30S (TP30) 
proceeds to completion i.e. 30S, while at and below 15 °C, it is stalled at 21S6, 103. 16S 
rRNA unmodified at positions A1518 and A1519 was reconstituted with TP30 at 40 °C 
and 15 °C. These reconstitution reactions were then assayed for KsgA activity at the 
respective temperatures. Purified natural 30S unmodified at A1518 and A1519 was tested 
as control.  
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Figure 12. (A) Magnesium dependence assay at 40 °C to determine the optimal Mg+2 
concentration for KsgA activity under the reconstitution salt conditions (B) In vitro time 
course assay at 15 °C to assess the methylation of 21S particles by KsgA. The Mg+2 
concentration in these reaction was 10mM, as found optimal in (A).  In both, (A) and (B), 
purified natural 30S subunits were used as a control. Diamonds indicate the control 
assays containing natural 30S subunits, whereas squares indicate assays containing the 
reconstitution product. 
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Figure 13. (A), (B) and (C) represent the sucrose gradient profiles of 16S rRNA + KsgA, 
30S + KsgA, and 30S, respectively. (D) SDS PAGE analysis of the peak collected from 
(A), (B) and (C), where 1- Protein Standards, 2- KsgA (control), 3- 16S rRNA + KsgA, 
4- 30S + KsgA and 5- 30S. 
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We found that natural 30S subunits are substrates to KsgA at both temperatures, 
however, only those reconstitution reactions that were incubated at 40 °C show 
methylation (Figure 12). Therefore, it appears that KsgA requires something more folded 
than 21S, which is known to be a loose assemblage relative to more mature particles like 
26S and 30S. Hence, our in vitro analysis is consistent with the observation that KsgA 
doesn’t act before the formation of in vivo 21S intermediates. The identification of the 
core eight ribosomal proteins was made by single and bulk omission reconstitutions using 
16S rRNA and different set of ribosomal proteins.  All of these reconstitutions were done 
at 42 °C, which means that a 21S-like particle was never formed. Therefore, the core 
eight proteins are required but not sufficient for KsgA function.  High temperature 
annealing is also required. 
Ribosome biogenesis occurs co-transcriptionally, which means that there is never 
free 16S rRNA available for ribosome assembly. Nevertheless, it is of interest to 
understand just how immature assembly can support KsgA binding, though not 
necessarily catalytic function. Therefore, we incubated 16S rRNA, which is known not to 
be a substrate, with KsgA in 1:5 ratio at 37 °C for 20 min before running it on a 10-30% 
sucrose density gradient. As control, 30S+KsgA and 30S alone were also treated 
similarly. Fractions containing 16S rRNA in each experiment were collected and 
concentrated. The presence of KsgA was assayed by SDS PAGE analysis. The KsgA/16S 
rRNA complex was clearly strong enough to survive a sucrose gradient. Therefore, it 
appears binding isn’t the only critical factor for function. Obviously, overall 30S and 
partial 30S subunit assembly is essential. 
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Figure 14. Crystal structure of the 30S subunit. In light gray ribbon is 16S rRNA except 
for the pair of apical adenosines of helix 45, which are yellow and blue, respectively, and 
are in space-filling representation. In green ribbon are those proteins necessary for KsgA 
activity. In red ribbon are those proteins that are refractory to KsgA activity. The 
remaining ribosomal proteins are in dark gray ribbon. The three domains of 30S are 
roughly delineated and labeled. (A) The subunit interface view of 30S. (B) The solvent 
exposed view of 30S. These figures were rendered using Pymol from the coordinates 
generated by Wimberly et al. (PDB ID 1J5E)14. 
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Our results indicate that KsgA does bind naked 16S rRNA (Figure 13) and can 
thus bind very immature particles. KsgA also binds 30S subunit in the inactive state108. 
Therefore, KsgA is likely to be able to bind the intermediate 21S particle, which then 
means that KsgA does not recognize 21S as a substrate for methylation, in vitro as well. 
Interaction of KsgA with ribosomal proteins is indirect 
            Inspection of where on 30S the proteins that activate KsgA function and the 
proteins that inhibit KsgA bind reveals that they are principally split between different 
domains of the 30S subunit14. The activating proteins are located within the platform and 
body while the inhibitory proteins reside within the head, with the exception of the 
platform-bound S21 (Figure 14). Importantly, none of the proteins from either set are 
spatially close to helix 45, which means that none are close to where KsgA must bind. 
Therefore, it is reasonable to imagine that KsgA is activated or inhibited indirectly, 
probably through formation of alternate 30S conformers. With regard to the activating 
proteins, single omission experiments report that some KsgA activity remains when all 
but S8 are individually omitted 96. This implies that none of the proteins directly activate 
KsgA, otherwise their omission would abolish all activity. On the other hand, the 
indispensable protein S8 is so far from helix 45 that it is inconceivable that it could 
directly interact with KsgA to activate its enzymatic function. 
Conclusions 
            Based on the existing literature and the data reported here, we conclude that the 
discrepancies between Thammana and Held96 and Poldermans et al.58 observations can be 
explained by the occurrence of a conformational change that occurs as late binding 
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proteins assemble onto the nascent 30S under conditions of high Mg2+ and NH4+. Before 
the head proteins bind, pre-30S is unable to adopt the ‘active’ conformation rejected by 
KsgA under all buffer conditions. But as the head proteins bind, a conformational shift 
occurs under the buffer conditions used by Thammana and Held that leads to a pre-30S 
and 30S that cannot be methylated by KsgA. However, this conformational shift does not 
occur under the buffer conditions that stabilize 30S into the translationally inactive state 
(intermediate NH4+ and low Mg2+), and KsgA can methylate such 30S. 
            Also, our data indicates that although KsgA binds naked 16S rRNA in vitro, it 
does not recognize as substrate the 21S particle that contains all the eight proteins 
essential for KsgA activity. Also, the dimethyladenosines are not present in the in vivo 
pre-30S particles analogous to the in vitro 21S particles7. Therefore, if KsgA recognizes a 
specific assembly state of 30S, it comes after 21S has formed. This leaves a very narrow 
window of opportunity for KsgA to methylate, since once 26S forms, the inhibitory 
ribosomal proteins readily assemble on96. This is true unless in vivo 30S passes through a 
conformation analogous to the in vitro inactive state discussed above, something that has 
not been observed in vivo but cannot be discounted as a possibility. At the very least it 
appears that the enzymatic action of KsgA is tightly controlled during ribosome 
biogenesis, which may have importance to the overall biological role of KsgA in E. coli 
and to the corresponding enzymes in other organisms. Deciphering the events of KsgA 
involvement in ribosome biogenesis will teach us more about in vivo ribosome assembly, 
because the two processes are linked. Furthermore, the strong conservation between the 
KsgA/Dim1 proteins in bacteria, archaea, and eukaryotes suggests that there are common 
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assembly milestones for all ribosomes. Identification of those putative common 
milestones is critical to our understanding of ribosome biogenesis in all domains of life. 
Experimental 
Preparation of KsgA 
 
Recombinant KsgA was obtained as previously described109. Briefly, the ksgA 
gene was amplified from E. coli genomic DNA using PCR (forward primer: 5' - 
ATCGCCCATATGATGAATAATCGAGTCCACCAGG; reverse primer: 5' 
ATTATGCTCGAGTTAACTCTCCTGCAAAGGCG) and cloned into a pET15b 
expression vector to include an N-terminal polyhistidine tag (pJPR1). BL21 E. coli cells 
transformed with pJPR1 were grown to an OD600 of 0.6 in the presence of ampicillin 
and induced with 1 mM IPTG (Sigma-Aldrich). After 4 hours at 37 °C, cells were 
harvested by centrifugation. Pellets were resuspended in lysis buffer (50 mM NaPO4, 300 
mM NaCl, 10 mM imidazole, pH 8.0), broken with two passages through an Emulsiflex 
cell breaker (Avestin), and centrifuged to remove cell debris. Cleared lysate was loaded 
onto a HiTrap Chelating column (Amersham) equilibrated with 0.1M NiSO4, washed 
twice with increasing amounts of imidazole (wash buffer 1: 50 mM NaPO4, 300 mM 
NaCl, 20 mM imidazole, pH 8.0; wash buffer 2: 50 mM NaPO4, 300 mM NaCl, 50 mM 
imidazole, pH 8.0), and the protein eluted with elution buffer (50 mM NaPO4, 300 mM 
NaCl, 250 mM imidazole, pH 8.0). Protein concentrations were estimated using the 
Bradford method. Purified protein was dialyzed into buffer containing 50mM Tris, pH 
7.4, 400mM NH4Cl, and 6mM  β-mercaptoethanol and stored in 10% glycerol at -80 °C. 
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Preparation of submethylated 30S ribosomal subunits 
To obtain 30S subunits unmethylated at A1518 and A1519 a standard procedure 
of selecting for strains of E. coli resistant (>600 µg/ml) to the antibiotic kasugamycin was 
followed110. Individual ribosomal subunits from one such strain (ksgR11) were obtained 
via ultracentrifugation across a sucrose gradient using standard techniques111. As a 
control, 30S particles fully methylated at A1518 and A1519 were obtained from wild-
type E. coli using the same isolation protocol. Aliquots of pure 30S subunits (wild-type 
and submethylated) were dialyzed into buffer A, I, or K and stored at -80 °C. Buffers: (A) 
20mM Tris–HCl, pH 7.4, 200mM NH4Cl, 20mM MgCl2, 20mM DTT; (I) 10mM Tris–
HCl, pH 7.4, 100 mM NH4Cl, 0.5mM MgCl2, 1mM 2-mercaptoethanol; (K) 40mM Tris–
HCl, pH 7.4, 40mM NH4Cl, 4mM MgOAc, 6mM β-mercaptoethanol. 
In vitro activity assay of KsgA 
The assay performed here is a slight variation of the one developed by 
Poldermans et al.58. All reactions were done in 50 µl volumes containing buffer A, I, or 
K, 0.02mM 3H-methyl-SAM (780 cpm/pmol), 7 pmol of 30S, and 7 ng of KsgA. 
Reactions proceeded for 30min at 37 °C, then the contents were deposited onto DE81 
filter paper (Whatman), washed twice with cold 5% trichloroacetic acid, and washed with 
cold ethanol. Air-dried filters were placed into scintillation fluid and counted. 
In vitro activity assay of reconstituted 30S and 21S particles 
16S rRNA was prepared as previously described by Moazed et al.112 and TP30 
was prepared as described by Nierhaus113. Buffers used for reconstitution were Rec A 
(20mM K+-HEPES (pH 7.5), 0 to 20 mM MgCl2, 330 mM KCl and 6mM BME) and Rec 
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A-. Rec A- is RecA buffer minus KCl. Reconstitution was done using 1:1.5 molar ratio of 
16S rRNA to TP30. A standard activity assay reaction contained 20 pmol 16S rRNA, 30 
pmol TP30, 20 pmol KsgA and 0.02 mM 3H-methyl-SAM (780 cpm/pmol). For the 
control reactions, 16S rRNA and TP30 were replaced by 20 pmol purified natural 30S. 
Since TP30 is stored in a buffer containing 1M KCl, the KCl concentration of the 
reaction mixture was adjusted to 330 mM using RecA and RecA- buffers. 
Mg+2 dependence assay was performed at 40 °C to determine the optimal Mg+2 
concentration for KsgA activity under the reconstitution salt conditions. For this assay, 
16S rRNA and TP30 were mixed in RecA buffer (concentration of KCl was adjusted with 
RecA- buffer) containing 4, 6, 8, 10, 12, 15 or 20mM MgCl2, and incubated at 42 °C for 
15 min before shifting the reactions to 40 °C. As a control, the same procedure was 
followed for natural 30S. After 10 min incubation at 40 °C, KsgA and SAM were added, 
and the reactions were allowed to proceed for 60 min. At the end of 60 min, the reactions 
were quenched, deposited on filter paper, washed, dried and counted as described above.  
KsgA showed maximum activity at 10 mM MgCl2. To test 21S as a substrate for 
KsgA, a time course activity assay was performed at 15 °C, at which temperature the 
reconstitution is stalled at 21S. All the reaction buffers and components were maintained 
on ice. Assay procedure was similar to that described above, except that for this assay 
16S rRNA and TP30 were mixed in RecA buffer (KCl concentration adjusted with RecA-
) containing 10mM MgCl2, and incubated at 15 °C for 15 min before adding KsgA and 
SAM. As a control, the same experiment was performed on natural 30S. 
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CHAPTER 3: Functional Conservation 
 
 
 
The presence and function of the KsgA/Dim1 family of enzymes have been 
maintained throughout all domains of life, including the eukaryotic cellular organelles58-
61, 63, 64
. Exceptions are rare50-52. However, KsgA is dispensable in bacteria with only 
modest consequences and forms the dominant mode by which bacteria become resistant 
to the aminoglycoside antibiotic kasugamycin57, 65. A KsgA knockout mutant shows 
slower growth rate in Escherichia coli and reduced virulence in the human pathogen, 
Yersina pseudotuberculosis66-68.  
The higher evolutionary members of this family have adopted secondary roles in 
ribosome biogenesis in addition to their dimethyltransferase role. Eukaryotic Dim1 is a 
member of the processome and is essential for proper processing of the primary rRNA 
transcript70. The human mitochondrial ortholog h-mtTFB, which is responsible for 
transferring methyl groups to the mitochondrial 12S rRNA, was originally demonstrated 
to be mitochondrial transcription factor63, 71. h-mtTFB has also been linked to hereditary 
deafness associated with a polymorphic A1555G mutation in mitochondrial rRNA72. In 
the cases of both Dim1 and h-mtTFB, the methylating activity is separate from the 
second function; methylation-deficient mutations can be made, which leave the rRNA 
processing or transcription activity intact76, 78. Pulicherla et al. recently confirmed that in 
Saccharomyces cerevisiae, none of the methyl groups transferred by Dim1 are critical for 
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growth under standard conditions and a variety of temperatures77. The key question that 
thus lingers is that why is the dimethyltransferase function still present and conserved 
universally. 
KsgA is able to methylate fully formed 30S subunits, although these subunits 
must be in a translationally inactive conformation to support methylation108. However, 
the true in vivo substrate for KsgA is unknown. A minimal in vitro substrate has been 
found to consist of 16S rRNA plus a subset of ribosomal proteins96.This suggests that 
KsgA methylates a discrete intermediate in the 30S assembly pathway. Dim1 and h-
mtTFB have been shown to complement for KsgA function in bacteria60, 63. This 
indicates that the bacterial, eukaryotic, and organellar enzymes can recognize a common 
bacterial substrate, despite differences in the respective 30S maturation processes.  
We have extended the previous complementation studies to include an archaeal 
ortholog MjDim1 from the organism, M. jannaschii. We have examined the activity of 
MjDim1 and Dim1 from S. cerevisiae (ScDim1) both in vivo and in vitro in bacterial 
systems. Our results indicate that the core methyltransferase activity of this family of 
enzymes, including recognition of a complex substrate, has changed little since the last 
ancestor. It also suggests that the basic structural components of the small ribosomal 
subunit, required for recognition by the enzymes have remained conserved. Although 
dispensable, the methyltransferase activity of the KsgA/Dim1 family of enzymes must 
have a role important enough to justify its preservation throughout the course of 
evolution. 
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Figure 15. Structure-based sequence alignment of KsgA (P06992), putative Dim from 
Homo sapiens (HsDim1, Q9UNQ2), ScDim1 (P41819), and MjDim1 (NP_248023). 
The alignment was generated using the TCoffee Web server114. Identical residues are 
denoted with a star, and strongly conserved residues with a colon; weakly conserved 
residues are marked with a period. Double-headed arrows indicate motifs common to 
SAM-dependent methyltransferases. Structures used for alignment were those of KsgA84 
(PDB ID 1QYR) and HsDim1115 (PDB ID 1ZQ9). 
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In vivo analysis 
 
ScDim1 has been shown to complement for KsgA function in ksgA– E. coli 
cells60, demonstrating functional equivalence of the two proteins. We asked whether 
MjDim1 could also complement KsgA knockout. In vivo activities of both ScDim1 and 
MjDim1 were assessed using a modified minimal inhibitory concentration (MIC) assay, 
which takes advantage of the fact that loss of KsgA function renders bacteria resistant to 
kasugamycin (ksg)59, 65. Plasmids containing the two proteins were transformed into a 
ksgR strain of E. coli, which lacks endogenous KsgA activity. This strain was constructed 
from BL-21 (DE3) cells; this allows leaky expression from the pET15b T7 promoter. 
Growth on ksg was compared to cells transformed with pET15b-KsgA plasmid (positive 
control) and cells transformed with empty vector (negative control).  
Unlike in a traditional MIC, untransformed cells are naturally resistant to the 
antibiotic and become sensitive when transformed with a functional dimethyltransferase. 
Therefore, cells transformed with KsgA have a low MIC of 400 µg/ml ksg, while cells 
transformed with empty vector have a high MIC, greater than 3000 µg/ml ksg. As shown 
in Figure 16, MjDim1 is fully functional in this in vivo system, with an MIC of 400 
µg/ml. ScDim1, on the other hand, shows partial activity on bacterial ribosomes in vivo, 
with an MIC of 1200 µg/ml. While ScDim1 does not restore full sensitivity to the 
antibiotic, it does show increased sensitivity, indicating that the enzyme is able to 
recognize the small subunit as a substrate. Lack of full complementation may correlate 
with slower and/or incomplete methylation of 30S as compared to the other two enzymes 
(see nucleoside analysis). 
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Figure 16. In vivo activity of KsgA orthologs 
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In vitro analysis 
We next asked how efficiently ScDim1 and MjDim1 were able to methylate E. 
coli 30S in an in vitro assay. Unmethylated 30S subunits were prepared from the ksgR 
strain described above. Incorporation of 3H-methyl from labeled SAM by each enzyme 
was followed at discrete time points over an interval of two hours. Control experiments 
were performed with 30S subunits purified from wild-type E. coli cells, which are 
methylated by endogenous KsgA and thus do not serve as substrates. Initial experiments 
were performed with 10 pmol of 30S substrate and 1 pmol of enzyme. This amount of 
protein did not allow for completion of the reaction within two hours, so experiments 
were also performed using 10 pmol each of 30S and enzyme. 
Figure 17, A-C, shows the time-course of methylation for KsgA, ScDim1, and 
MjDim1 respectively. Methylation of E. coli 30S by ScDim1 and MjDim1 closely 
followed the KsgA time-course, both in rate of incorporation and final level of 
methylation. In reactions with 1 pmol of protein, MjDim1 showed a slightly higher rate 
of 3H incorporation than KsgA and ScDim1 at later time points. With stoichiometric 
amounts of protein relative to 30S, the time-course of methylation was essentially 
indistinguishable between the three proteins, confirming the ability of the enzymes from 
archaea and eukaryotes to recognize bacterial 30S subunits as substrates.  
We then estimated the amount of methyl groups transferred at the 2h time point 
by each enzyme, with both 1 pmol and 10 pmol amounts of enzyme, by constructing a 
standard curve of cpm versus concentration of 3H-methyl-SAM (Figure 18). With 10 
pmol of 30S per reaction, and four methylation sites per 30S molecule, we would expect  
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Figure 17. SDS PAGE analysis of KsgA, ScDim1 and MjDim1 proteins to assess purity.  
‘L’ represents reference protein ladder (Precision Plus Protein Dual Color Standards, Bio-
Rad). 
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Figure 18. In vitro methylation of 30S. Time-course assays for KsgA (A), ScDim1 (B), 
and MjDim1 (C). Blue lines indicate assays containing 10 pmol ksgR 30S, 10 pmol 
enzyme and orange lines indicate assays containing 10 pmol ksgR 30S, 1 pmol enzyme. 
Assays were performed in triplicate; error bars represent standard deviation. 
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Figure 19. Quantitation of methyl groups transferred after two hours. Blue bars represent 
assays performed with 10 pmol enzyme; orange bars represent assays using 1 pmol 
enzyme. Assays were performed in triplicate; error bars represent standard deviation. 
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to see transfer of 40 pmol methyl groups per 10 pmol of 30S if the reactions have gone to 
completion. As shown in Figure 19, our calculations lead to slight overestimation of 
methyl group transfer, probably due to error in 3H counting. Nevertheless, the reactions 
performed with 10 pmol enzyme appear to be more or less complete after 2 hours. 
Reactions performed with only 1 pmol enzyme are approximately halfway completed 
after 2 hours. 
Nucleoside analysis 
In vitro assays of the three proteins, performed as described above for the time 
course, were incubated for two hours and analyzed to determine relative amounts of m6A 
and m62A (Figure 20; Table 1). 16S rRNA isolated from 30S subunits methylated by 10 
pmol of either KsgA or MjDim1 contained no detectable labeled m6A; radioactive 
incorporation was seen only in the dimethyladenosine peak. This agrees with the in vitro 
data suggesting that these reactions have gone to completion (Figure 19). ScDim1, on the 
other hand, produced a mixture of m6A and m62A; approximately 28% of the 
incorporated radiolabel was found on monomethylated adenosine. This indicates that at 
most 80% of the potential sites were methylated after two hours. 
Partially methylated 30S from reactions using 1 pmol of enzyme showed 
radioactive peaks at both m6A and m62A. Surprisingly, although the total level of 
methylation was similar for all three enzymes (Figure 19), rRNA methylated by the 
different enzymes showed different ratios of m6A to m62A. ScDim1 produced 
approximately 1.4 times as much m6A as m62A. MjDim1, conversely, produced almost no 
m6A; only about 1% of the incorporated methyl groups were found on m6A. KsgA fell  
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Figure 20. Representative HPLC trace. The bottom trace, plotted as cpm vs. time (shifted 
upward by 50 cpm), represents scintillation data from a control assay using wild-type 30S   
The middle trace (shifted upward by 250 cpm) represents scintillation data obtained from 
an assay using 1 pmol ScDim1 and 10pmol ksgR 30S. At the top is the UV trace, plotted 
as A254 vs. time (shifted upward by 1 OD unit), representing the reference nucleotides, 
with m6A and m62A peaks labeled. 
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Table 1. Quantitation of methylated adenosine species 
 Total CH3 (pmol)a Ratio m6A:m62A m6A (pmol) m62A (pmol)b 
KsgA 
1 pmol 
10pmol 
 
18.1 ± 1.7 
37.4 ± 10.1 
 
0.8:1 
– 
 
5.2 
NDc 
 
6.5 
18.7 
ScDim1 
1 pmol 
10pmol 
 
20.1 ± 0.7 
47.4 ± 2.7 
 
1.4:1 
0.8:1 
 
8.3 
13.5 
 
5.9 
16.9 
MjDim1 
1 pmol 
10pmol 
 
24.1 ± 3.6 
48.1 ± 8.8 
 
0.02:1 
– 
 
0.2 
NDc 
 
11.9 
48.1 
 
aData from Figure 19 
b1 pmol m62A corresponds to 2 pmol methyl groups 
cND = none detected  
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somewhere between the other two, producing both m6A and m62A, with only 0.8 times as 
much m6A as m62A. These results could be an outcome of assaying enzymes from 
different species on the bacterial substrate, or they could reflect a difference in reaction 
mechanism. 
The KsgA/Dim1 enzymes transfer a total of four methyl groups from four SAM 
molecules to two adenosines. The exact mechanism of transfer has not yet been 
established; questions remain as to order of addition, if any, and the number of binding 
events required for the four methylations. The above data begin to address the question of 
the multiple methyl group transfers. Partially methylated 30S were produced in reactions 
containing 10 pmol 30S subunits and 1 pmol enzyme. Therefore, m6A produced in excess 
of 2 pmol (corresponding to two adenosines available for methylation per subunit) will 
only be seen if the enzyme releases the substrate after monomethylation and rebinds to a 
new substrate. With 20.1 pmol of methyl groups incorporated by 1 pmol ScDim1, the 
1.4:1 m6A: m62A ratio represents approximately 8.3 pmol labeled m6A and 5.9 pmol 
labeled m62A (1 pmol m62A represents 2 pmol incorporated methyl groups). Therefore, 
under our assay conditions, ScDim1 clearly releases the m6A intermediate, which is 
subsequently converted to the m62A product after an additional binding event. 
In contrast, there is no indication that MjDim1 produces m6A as anything but a 
transient intermediate. Of the 24.1 pmol methyl groups transferred, only 0.3 pmol were 
found on m6A. These results suggest that the archaeal enzyme preferentially forms 
dimethyladenosine, without release of the monomethyl intermediate. While release of a 
monomethyl intermediate and subsequent re-binding and addition of the second methyl 
  59 
cannot be ruled out, such a model requires that MjDim1 prefer the monomethylated 
substrate to the unmethylated substrate to a large degree. 
In terms of m6A versus m62A production, KsgA falls somewhere in between 
ScDim1 and MjDim1. Unlike ScDim1, KsgA produces less m6A than m62A; however, of 
the 18.1 pmol of methyl groups transferred, 5.2 pmol are found on m6A, which is still 
indicative of a released intermediate. Although it is possible that these differences are a 
result of suboptimal assay conditions, these results also allow the possibility of distinct 
mechanisms for the three enzymes, thus demonstrating a need for future analysis to 
dissect the exact scheme of methyl transfer. 
Conclusions 
Substrate recognition by the KsgA/Dim1 methyltransferases is complex. KsgA is 
able to methylate 30S subunits under conditions of low Mg2+, but it can also methylate a 
pre-ribosomal particle containing 16S and a partial complement of ribosomal proteins96. 
Dim1 is essential for early processing of the pre-18S rRNA, but does not methylate 18S 
until very late in the 40S maturation process70. Despite evolutionary divergence of 
ribosomal assembly and processing pathways, eukaryotic and archaeal KsgA orthologs 
are able to methylate E. coli 30S both in vivo and in vitro. This requires the conservation 
of similar structural cues in small ribosomal subunits across evolution. Also complex is 
the mechanism of the modification performed by these enzymes. A total of four methyl 
groups are transferred, from four SAM molecules, to two separate adenosines. It is clear 
from the crystal structure of KsgA84 that only one SAM molecule is bound at a time, and 
that the adenosines enter the active site separately. It has not been determined in what 
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order, if any, the methyl groups are transferred, or if all four of the transfers take place 
within a single or multiple binding events. The work presented here demonstrates clear 
differences in the reaction intermediate profiles produced in vitro by KsgA enzymes from 
bacteria, archaea and yeast, despite the fact that the three enzymes methylate bacterial 
30S to a similar extent and at similar rates in the assay used.              
However, we cannot exclude the possibility that the differences in the respective 
rates of m6A and m62A production seen here are a result of suboptimal substrate or assay 
conditions rather than a reflection of true differences in mechanism. For example, the 
yeast and archaeal enzymes may show different activity if assayed on their respective 
small ribosomal subunits rather than on bacterial 30S. Our results demonstrate the 
remarkable cross-recognition of a complex substrate by evolutionarily distant members of 
an enzyme family and emphasize the need to further investigate the multi-step reaction 
mechanism. 
Experimental 
Cloning 
KsgA gene from E. coli and MjDim1 gene from M. jannaschii were previously 
cloned in our laboratory into the pET15b vector, in-frame with the vector-encoded N-
terminal poly-histidine tag, and was confirmed by sequencing. The pET15b-ScDim1 
construct was provided by Dr. Jean Vandenhaute, and was also confirmed by sequencing. 
Protein expression and purification 
pET15b-KsgA and pET15b-MjDim1 plasmids were transformed into BL-21 
(DE3) cells for overexpression. Cell cultures were grown to an OD600 of 0.6 in the 
  61 
presence of ampicillin and induced with 1 mM IPTG (Sigma-Aldrich). After 4 hours at 
37 ºC, cells were harvested by centrifugation. Pellets were resuspended in lysis buffer (50 
mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0), broken with two passages 
through an Emulsiflex cell breaker (Avestin), and centrifuged to remove cell debris. 
Cleared lysate was loaded onto a HiTrap Chelating column (Amersham) equilibrated 
with 0.1M NiSO4, washed twice with increasing amounts of imidazole (wash buffer 1: 50 
mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0; wash buffer 2: 50 mM 
NaH2PO4, 300 mM NaCl, 50 mM imidazole, pH 8.0), and the protein eluted with elution 
buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0).  
ScDim1 protein was expressed in BL21-CodonPlus (DE3)-RIL cells (Stratagene). 
The cells were grown at 37 ºC to an OD600 of 1.2 in the presence of ampicillin. Then the 
protein was induced under mild conditions with 0.1 mM IPTG and transferred to 25 ºC 
for four hours. Cells were harvested and broken as for KsgA and MjDim1. Purification 
was carried out by affinity chromatography using a Ni2+ column; buffers included 15% 
glycerol and 3 mM β-mercaptoethanol along with the above concentrations of NaH2PO4, 
NaCl and imidazole. To increase the stability of the protein, glycerol and β-
mercaptoethanol were added to the purified protein to final concentrations of 25% and 6 
mM, respectively. 
Proteins were estimated to be >95% pure by SDS-PAGE analysis. Protein 
concentration was measured using the Bradford method (Bio-Rad Protein Assay). 
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30S purification 
An E. coli strain lacking functional KsgA was constructed by growing BL-21 
(DE3) cells on kasugamycin (ksg) to select for loss of the dimethylations. 30S ribosomes 
from this ksgR strain were used in an in vitro assay to confirm that the adenosines were 
able to be methylated and therefore that the resistance to ksg was due to lack of KsgA 
activity. 30S subunits from both the ksgR strain and the wild-type strain were prepared as 
previously described116, except that cells were broken as described above. Purified 
subunits were dialyzed into reaction buffer (40 mM Tris, pH 7.4; 40 mM NH4Cl; 4 mM 
MgOAc; 6 mM β-mercaptoethanol) and stored at –80 ºC in single-use aliquots. 30S 
concentration was estimated by measuring the absorbance at 260 nm and using a 
relationship of 67 pmol 30S per 1 unit of optical density. 
In vivo assay 
ksgR cells were transformed with the pET15b constructs and selected on LB plates 
containing ampicillin. Transformed colonies were picked into liquid media and grown in 
overnight culture. These cultures were diluted 1:25 in fresh LB (Luria-Bertani media) 
containing 50 µg/ml ampicillin and grown to OD600 of 0.7-0.8, diluted 1:100 in fresh 
LB, and plated onto LB/ampicillin containing increasing amounts of ksg, from 0 to 3000 
µg/ml. Plates were incubated at 37 ºC overnight and visually inspected for colony 
formation. 
In vitro assay 
The in vitro assay was adapted from Poldermans et al.58. Time-course reactions 
were performed in 500 µl volumes containing 40 mM Tris, pH 7.4, 40 mM NH4Cl, 4 mM 
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MgOAc, 6 mM β-mercaptoethanol, 0.02 mM 3H-methyl-SAM (780 cpm/pmol; MP 
Biomedicals), 100 pmol 30S subunits, and 10 or 100 pmol enzyme; volume and 
components were sufficient for 10 reactions. Buffer and reagents were pre-warmed to 37 
ºC and added into pre-warmed tubes to minimize any lag in the reaction start. At each of 
eight designated time points 50 µl was removed and added to a pre-chilled tube 
containing 10 µl of 100 mM unlabeled SAM (Sigma-Aldrich) to quench the reaction; the 
remaining 100 µl was stored at –20 ºC and used for HPLC analysis (see below). The 
quenched reactions were deposited onto DE81 filter paper (Whatman), washed twice with 
ice-cold 5% TCA, and rinsed briefly with ethanol. Filters were air-dried for one hour, 
placed into scintillation fluid, and counted. 
HPLC analysis 
Labeled 16S rRNA was extracted from 30S subunits with 
phenol/chloroform/isoamyl alcohol. 16S was digested and dephosphorylated as described 
by Gehrke and Kuo117, and subjected to nucleoside analysis by reversed-phase HPLC. 
Nuclease P1 was obtained from USBiological, shrimp alkaline phosphatase was from 
MBI Fermentas. HPLC analysis was performed on a Polaris C-18 column (Varian). The 
HPLC system used consisted of a Waters 600 Controller, a Waters 2487 Dual λ 
Absorbance Detector, and Waters Empower software. Radioactivity was monitored with 
a Packard 150TR Flow Scintillation Analyzer. Buffer A was 20 mM NaH2PO4, pH 5.1. 
Buffer B was 20 mM NaH2PO4 (pH 5.1): acetonitrile, 70:30. Separation was performed at 
room temperature using a linear gradient from 100%A-100%B over 20 min, at a flow rate 
of 1.0 ml/min. Nucleoside standards used were N6-methyladenosine (Sigma-Aldrich) and 
  64 
N6 N6-dimethyladenosine, synthesized as in Rife et al.102  Peak integration was calculated 
by the Empower software and used to determine ratios of m6A:m62A. 
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CHAPTER 4: A preliminary examination of the 16S rRNA sites 
implicated in KsgA binding 
 
 
 
Ribosome biogenesis is a fundamental cellular process yet it follows strikingly 
different pathways in prokaryotic, eukaryotic and archaeal cells24, 104.Similarities are 
extremely rare. Within such divergence, the conservation of KsgA/Dim1 family of 
methyltransferases is unique, since it represents the only rRNA post-transcriptional 
modification enzymes that appear to be conserved in all three domains of life59-61. The 
conservation also extends into mitochondria and chloroplasts63, 64.  
The enzyme was first described in E. coli, where it catalyzes the conversion of 
two adjacent adenosines A1518 and A1519, also conserved, in the 30S subunit rRNA to 
N6,N6-dimethyladenosines57, 58. The methyltransferase has since been described in 
eubacteria59, archaeabacteria62, eukaryotes60, 61 and in cellular organelles63, 64.  
Connolly et al. recently offered a mechanistic explanation for the extreme 
conservation of the KsgA/Dim1 family of enzymes69. They suggest that KsgA functions 
as a late stage ribosome biogenesis factor and that the methylation triggers release of 
KsgA from the assembling subunit, allowing it to finally mature and enter the translation 
cycle with the speculation that it functions as a gatekeeper. On the other hand, Dim1 had 
the additional role of being an essential member of the processome. Connolly et al. also 
reported that a ∆ksgA genotype in E. coli is linked to cold sensitivity and altered 
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ribosomal profiles, and that a methyltransferase-inactive form of KsgA is profoundly 
deleterious to cell growth and ribosome biogenesis69.  
The binding site of KsgA on the 30S ribosomal subunit is thought to overlap with 
that of IF3 binding site and 50S subunit association sites91. Xu et al. observed that 
addition of IF3 lead to a loss of directed cleavage of 16S rRNA by KsgA in their 
hydroxyl radical probing experiments91. Hence, one of the roles of KsgA could be to 
occlude these translational components from binding until an ‘appropriate’ assembly of 
structurally and functionally competent 30S subunit has occurred91. These recent 
additions to the roles and importance of KsgA in prokaryotes prompt the consideration of 
KsgA as a potential antimicrobial drug target. 
In order to gain complete insight into the role of KsgA in ribosome biogenesis and 
how it interacts with other ribosome biogenesis factors or chaperons, it is extremely 
important to determine the binding site of KsgA on the 30S subunit. However, there 
seems to be a great deal of incongruity in the literature regarding this information. The 
model of KsgA-16S rRNA complex, proposed by Xu et al.91 based on hydroxyl radical 
probing and footprinting data, positions KsgA such that its N-terminal domain interacts 
with the 790 loop of 16S rRNA and almost the entire protein interacts with the top 
portion of helix 44 in a linear fashion. This arrangement puts the target adenosines of 
helix 45 within close proximity to the active site of KsgA (motif VIII)84, but KsgA never 
binds helix 45.  
On the other hand, Tu et al. recently reported the crystal structure of Aquifex 
aeolicus KsgA bound to double stranded RNA via the cleft between its N- and C-terminal 
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domains99. The RNA used in their study represents the helix 45 of E. coli 16S rRNA. 
Helix 45, according to the structure of E. coli 30S subunit18, forms a hairpin structure 
capped by a GGAA tetraloop that contains the target adenosines methylated by KsgA. 
However, the KsgA-RNA crystal structure reported by this group shows a duplex formed 
by the association of two RNA molecules instead of a hairpin formed by a single RNA 
molecule. This unnatural form of RNA leaves room for skepticism on whether KsgA 
truly binds helix 45 in vivo.  Moreover, the mode by which KsgA interacts with 16S 
rRNA is also different as per the above two reports. The different binding modes require 
dramatically different mechanistic details of KsgA. 
We examined the 16S rRNA sites implicated by the above models in binding to 
KsgA using site directed mutagenesis and in vitro methods. Our results indicate that 
KsgA does not bind at the site of methylation and support the proximity model, whereby 
KsgA remains anchored to helix 44/790 loop and awaits the presentation of the target 
adenosines in the loop of helix 45.  
Sites of mutation 
To interrogate, we made mutations in the helix 24, helix 44 and helix 45 of the E. 
coli 16S rRNA (Figure 21).  
Helix 24 mutations 
The hydroxyl radical probing and footprinting data reported by Xu et al. indicates 
that the 790 loop, G785-C797, of helix 24 makes direct interactions with KsgA91. 
However, their model of KsgA-16S rRNA complex puts this region of 16S rRNA into a 
steric clash with KsgA.  There is a possibility that the conflict is an adverse effect of  
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A1418C
Del2bp
Add2bp
Del790loop
A1483C
DelHel45
                   
 
 
 
 
 
Figure 21. Location of the mutated nucleotides in the sequence and secondary structure 
of E. coli 16S rRNA. rRNA image adapted from Noller et al.118. 
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creating the model using 16S rRNA of 30S subunit in active conformation, which is not 
the true substrate for KsgA108. Therefore, we wanted to study how KsgA interacts with 
the 790 loop of 30S subunit that is in the inactive conformation.   
G791 of the 790 loop is a highly conserved nucleotide. Cunningham et al. has 
mutated this nucleotide to analyze its role in protein synthesis119. From their work, we 
know that G791 mutations retain at least intermediate activity and therefore such mutant 
30S can be assembled properly to a significant proportion. Thus, we chose G791 for our 
study and independently mutated it to A, C and U. Also, we created the Del790loop 
mutant by removing nucleotides G785-C797 and replacing them with a GAAA tetraloop 
to retain the overall topology of the region. 
Pure, in vivo-derived mutant 30S ribosomal subunits for our assays were obtained 
using the MS2 affinity purification system developed by Youngman and Green120. In this 
approach, the 16S rRNA of mutant ribosomes is expressed from a plasmid-borne operon 
in a background of wild-type ribosomes. The system allows inducible expression of 
tagged ribosomes, permitting the expression of even dominant-negative 16S rRNA 
mutants. The mutant ribosomes are affinity tagged with an RNA stem-loop that allows 
specific binding to the coat protein of the MS2 bacteriophage; the MS2 coat protein is in 
turn immobilized as a fusion with glutathione S-transferase (GST) to a glutathione 
matrix. At low Mg+2 concentrations (0.3 mM), the 70S subunit falls apart into its 
constituent subunits111, hence buffers with low Mg+2 concentrations were used on the 
affinity column to selectively retain mutant 30S and wash away any 50S subunits bound 
to them. The advantage of the MS2 affinity system is that it is efficient and since the  
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Figure 22. Sucrose gradient analysis to assess the structural integrity of 30S subunits. 
250 pmols of 30S were loaded on to 10-30% sucrose density gradients. The fractions 
were collected from top to bottom. The 16S rRNA carrying Del790loop mutation did not 
form any 30S. The numbers 1-4 on the gradient profiles indicate peaks of subunit 
assembly products, where peak 4 contains fully formed 30S subunits whereas the others 
are intermediates. Peak 1 of G791C could not be collected due to a technical problem 
with the fraction collector. 
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mutant 30S subunits are assembled in vivo, they do not suffer from severe functional 
limitations that are encountered with in vitro reconstituted subunits.   
The purified mutant 30S subunits were assessed for their structural integrity by 
running them on 10-30 % sucrose density gradients prepared in low magnesium buffer 
(Figure 22). Untagged wild-type 30S purified from MRE600R strain and tagged wild-type 
30S (has the MS2 tag in its 16S rRNA, but no mutation) purified from DH5αR+ pcI+ 
pSpurMS2 strain were run as a control. The MS2-tagged 30S subunits migrate as heavier 
species than the untagged ones (Figure 22A, B). Youngman and Green had observed a 
similar phenomenon with tagged 50S and attributed it to the GST-MS2 fusion protein 
bound to the ribosomes120. The mutant Del790loop, unfortunately, did not form any 
detectable 30S. It was intriguing that the profiles, including that of the tagged wild-type 
30S, showed similar multiple intermediate assembly products at the top of the gradient 
before the actual 30S peak (peak 4). This phenomenon was not observed in case of MRE 
600R untagged 30S. Therefore, it seems that the presence of MS2 tag causes a slight 
reduction in the efficiency of 30S subunits to assemble, which may then be aggravated by 
the presence of mutations. We collected the individual peaks for each mutant and assayed 
them for methylation by KsgA. For the G791C mutant, we could not collect the first peak 
due to a technical problem with the fraction collector. 
In vitro analysis 
We first compared the ability of KsgA to methylate 30S subunits bearing the MS2 
tag to that of the untagged 30S (Figure 23A). Experiments were carried out with tagged 
wild type 30S subunits purified from Kasugamycin (ksg) resistant (Tagged-WT) and ksg 
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sensitive (WT Tagged-WT) DH5α cells, and untagged 30S subunits purified from ksg 
resistant MRE600 cells (Untagged MRE600R). The incorporation of 3H-methyl from S-
adenosyl methionine (SAM) into the 30S was followed at discrete time points over an 
interval of 2 h. The concentration of Mg+2 in the reactions was adjusted to 4mM, a value 
shown to be optimal for KsgA function58. The Tagged-WT 30S showed fewer 
scintillation counts than the untagged 30S subunits, however this difference was within 
the range of error.  
We then assayed the ability of KsgA to methylate the mutant subunits. The 
activity of assembly intermediates and 30S subunits collected from the sucrose gradients 
was compared to that of subunits not subjected to sucrose gradient, in a 2hr end point 
assay (Figure 23B). As control, this experiment was also performed with tagged wild-
type 30S. Peaks 1, 2 and 3 did not yield enough subunits to perform a full reaction and 
hence, for those peaks, the reaction components and volume were reduced to half. These 
peaks, which represent intermediates of 30S subunit assembly, showed no activity and so 
were not pursued further. However, this data provided an important observation that 
KsgA does not methylate early intermediate assembly particles.  
The G791 mutant subunits from the largest particles were approximately 50% as 
active as the wild type, with G791U being the most active of all. The subunits not 
subjected to sucrose gradients (non sucr grad, Figure 23B) are the pool of tagged subunits 
purified off the GST-affinity column. It was surprising that, in case of the mutants as well 
as the control, the non-sucrose gradient subunits showed greater activity than the pure  
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Figure 23. In vitro methylation assay of subunits. (A) Time-course assays for various 
control 30S subunits. (B) 2 h end point assay. The activity of assembly intermediates and 
30S subunits collected from the sucrose gradients was compared to that of subunits not 
subjected to sucrose gradient. Time course assay for 790 loop mutants (C) and (D). The 
difference between (C) and (D) is that the 30S subunits used in (D) were subjected to a 
sucrose gradient for assessing their structural integrity. (E) Number of pmol of methyl 
groups per 10 pmol of 30S transferred after 2h. All the above reactions contained 200nM 
KsgA, 200nM subunits and 0.02 mM, 780cpm/pmol 3H-methyl-SAM. However, due to 
insufficient yield of subunits, the reaction volumes for peak 1, 2 and 3 were reduced to 
half that of others. Assays were performed in triplicate; error bars represent standard 
deviation. CPM stands for Counts per Minute 
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30S subunits isolated via sucrose gradients (peak 4). To further understand this 
unexpected difference, we followed the methylation of both types of subunits over the 
course of two hours (Figure 23C, D). Although the overall activity trends in (C) and (D) 
did not look very different, the scintillation count of each reaction in (D) was lower than 
its counterpart in (C). Also notable is the slow onset of methylation in case of (D). 
Del790loop showed just above background activity. This was not surprising given the 
fact that no 30S subunits were detected for this mutant by sucrose gradient analysis 
(Figure 22F). 
           We also determined the extent of methylation at the 2 h time point for both, 
sucrose gradient purified 30S and non-sucrose gradient 30S subunits of each mutant 
(Figure 23E) using the specific activity of 3H-methyl-SAM. With 10 pmol of 30S per 
reaction, and four methylation sites per 30S molecule, we would expect to see transfer of 
40 pmol methyl groups per 10 pmol of 30S if the reactions have gone to completion. As 
can be seen in Figure 23E, the non-sucrose gradient Tagged-WT reaction appears to have 
reached completion whereas that of sucrose gradient Tagged-WT seems to be lagging 
behind. Also, the sucrose gradient reactions of G791 mutants show less methylation as 
compared to their non-sucrose gradient reactions. This may be due to partial deterioration 
of 30S subunits, caused by the extra handling steps involved in sucrose gradient analysis. 
Hence, for the subsequent mutants, only the non-sucrose gradient 30S subunits were 
assayed.  
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Figure 24. HPLC traces. (A), (B), (C) and (D) respectively represent the traces of Tag-
WT, G791A, G791C and G791U, at the end of a 2 h reaction.  At the top is the UV trace, 
plotted as A254 (arbitary units) vs. time, representing the reference nucleotides, with m6A 
and m62A peaks labeled. At the bottom is the scintillation trace, plotted as cpm vs. time, 
showing the type and extent of methylation. 
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Table 2. Extent of methylation of wild type and G791 mutant 30S by KsgA. Normalized 
percent is the ratio of mutant to wild type area under peak/nmol x 100.  
* Area under the dimethyladenosine scintillation peak. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutation Conc. of sample (nmol/80 µl) 
Area under the 
peak* 
Area under 
peak/nmol 
Normalized 
percent (%) 
Tag-WT 15.36 3253763 211833.52 100 
G791A 19.68 2264810 115081.80 54.32 
G791C 13.28 1872381 140992.54 66.55 
G791U 15.2 1714992 112828.42 53.26 
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Nucleoside Analysis 
            As seen in Figure 23E, for both sets, the G791 mutants showed approximately 
50% methylation as compared to Tagged-WT. We asked if the reduced activity of the 
mutants came from poor binding of KsgA to such 30S or was due to reduced catalysis 
resulting from the disruption of important interactions between KsgA and G791. The 
KsgA/Dim1 enzymes transfer a total of four methyl groups from four SAM molecules to 
two adenosines. Therefore each adenosine should be dimethylated. However, we have 
previously established that the KsgA/Dim1 enzymes produce a mixture of 
monomethyladenosines (m6A) and dimethyladenosines (m62A) when they cannot bind 
their substrates tightly62, 121. Therefore, to determine whether the observed reduction in 
the methylation was the result of reduced KsgA binding, we performed nucleoside 
analysis using HPLC to measure the ratio of m6A and m62A.                       
 For this analysis, only the non-sucrose gradient 30S subunits were used. In vitro 
assays for all three mutants and the control were incubated for two hours. At the end 
point, the 16S rRNA was extracted from the 30S subunits and subsequently digested and 
dephosphorylated. Component nucleosides were separated by reversed-phase HPLC. 
Peaks corresponding to m6A and m62A were assigned by comparison to reference 
nucleosides (Figure 24). Extent of methylation was determined by calculating the area 
under the m62A scintillation peak per nmol for each mutant and then normalizing the 
values to that of Tag-WT. 
           16S rRNA isolated from none of the mutant 30S subunits contained measurable 
amounts of labeled m6A. Although only about 50% of the potential sites were methylated 
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in case of G791 mutants, almost 100% of the incorporated radiolabel was seen in the 
dimethyladenosine peak. Such predominance of m62A clearly indicates that the mutations 
at G791 do not diminish the ability of 30S to be involved in a tight complex with KsgA. 
This, together with the fact that G791 lies in close proximity to the target adenosines and 
catalytic core of KsgA in Xu’s model91, indicates that the reduced activity of the mutants 
must be due to reduced catalysis resulting from the disruption of important interactions 
between KsgA and G791.  
Helix 44 Mutations 
           Another region of 16S rRNA that defines the binding site of KsgA, as per the 
KsgA-16SrRNA model proposed by Xu et al., is helix 4491. To test this premise, we took 
advantage of the well conserved tandem sheared A•G base pairs, G1417•A14183 and 
A1418•G1482, of helix 44 (Figure 25). According to Xu’s model, the adenosines of these 
base pairs make primary interactions with the highly conserved residues R221, R222 and 
K223 of the C-terminal domain of KsgA83, 91.  
            The characteristic of two consecutive sheared A•G base-pairs is that, although 
each A•G base pair can distort the helix individually, when a G•A base pair is followed 
by another A•G base pair, they are arranged such that the distortion caused by the first 
base pair is compensated by that caused by the other, thus maintaining the overall 
regularity of the helix122, 123. We created the A1418C and A1483C mutants, in which the 
corresponding sheared A•G base pair was replaced by a C:G base pair. The helix 44 of 
these mutants, carrying only one of the two consecutive sheared A•G base pairs, should 
be fairly distorted. Therefore, if the interaction between KsgA is governed to an  
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Figure 25. (A) Secondary structure of Helix 44 and 45 showing the location of the 
tandem sheared A•G base pairs. A1418 and A1483 were mutated to a C, one at a time. 
rRNA image adapted from Noller et al.118 (B) Chemical structure of sheared A•G base 
pair, as per Gutell et al.122   
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Figure 26.  Sucrose gradient analysis of A1418C (A) and A1483C (B) mutants. (C) Time 
course activity assay of affinity purified, non-sucrose gradient, mutant 30S subunits. (D) 
Number of pmol of methyl groups transferred after 2h. The reactions in (C) contained 
200nM KsgA, 200nM subunits and 0.02 mM, 780cpm/pmol 3H-methyl-SAM. Assays 
were performed in triplicate; error bars represent standard deviation. CPM stands for 
Counts per Minute. 
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important degree by the local structure around A1418 and A1483, then mutation of these 
residues should affect KsgA’s ability to bind and modify 30S subunits.             
 For our assays, pure mutant 30S subunits were obtained using the MS2 affinity 
purification system. Structural integrity of the mutant 30S subunits was assessed by 
sucrose density gradients. The sucrose gradient profiles were comparable to that of the 
G791 mutants (Figure 26A and B). Time course assays were performed in triplicate for 
the affinity purified, non-sucrose gradient, mutant 30S subunits (Figure 26C). As a 
control, Tagged-WT 30S were also assayed. The amount of methyl groups transferred at 
the end of 2 h was determined using specific activity of 3H-methyl-SAM (Figure 26D).  
           A1418C showed 10% less activity as compared to Tagged-WT, whereas A1483C 
mutant showed wild type activity in terms of the total number of methyl groups added. It 
was remarkable that although their reactions reached near completion at the end of 2 h, 
both mutants showed slower onset of activity as compared to wild type. It is possible that 
the distortion in mutant helix disrupts KsgA binding, causing it to fall off more 
frequently, thereby reducing the initial rate of reaction. If this is true, KsgA must produce 
a mixture of m6A and m62A. To follow the type of methylation produced by KsgA along 
the course of two hours, we performed nucleoside analysis of the time course assays. 
            For both mutants, even at the 2 minute time point, almost all incorporated 
radiolabel was in the form of m62A (Figure 27). No detectable m6A was found to indicate 
that the slow onset of activity is due to poor binding of KsgA to mutant 30S subunits. It 
therefore appears that the slow onset and the marginally reduced activity at the end of 2 h 
are the result of helical distortion affecting catalysis. However, mutation of R221-K223  
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Figure 27. HPLC traces. (A), (C) and (E), respectively, represent the traces of Tag-WT, 
A1418C and A1483C reactions at the 2 min time point, whereas (B), (D) and (F) 
represent the respective traces at the end of 2 h. The top and bottom traces are as 
described in Figure 24. 
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Table 3.  Extent of methylation of wild type and helix 44 mutant 30S by KsgA at 2, 5, 
10, 30, 60 and 120 min. Normalized percent is the ratio of mutant to wild type area under 
peak/nmol x 100.  
* Area under the dimethyladenosine scintillation peak. 
 
 
 
 
 
Mutation Time (min) 
Conc. of sample 
(nmol/80 µl) 
Area under 
the peak* 
Area under 
peak/nmol 
Normalized 
percent (%) 
Tag-WT 
2 
5 
10 
30 
60 
120 
14.88 
14.56 
15.2 
14.88 
15.68 
15.36 
2094513 
2335944 
2657800 
2807826 
3044237 
3253763 
140760.28 
160435.71 
174855.26 
188697.98 
194147.76 
211833.52 
66.44 
75.73 
82.54 
89.07 
91.65 
100 
A1418C 
2 
5 
10 
30 
60 
120 
 
10.08 
13.28 
12.64 
10.4 
9.28 
12.16 
 
716950 
1536793 
1792748 
1602480 
1509784 
2258209 
 
71125.99 
115722.36 
141831.32 
154084.61 
162692.13 
185707.97 
33.57 
54.62 
66.95 
72.73 
76.80 
87.66 
A1483C 
 
2 
5 
10 
30 
60 
120 
 
 
13.6 
16.32 
15.68 
13.76 
13.12 
15.2 
 
1452401 
1968382 
1969140 
2176047 
2498835 
3147252 
106794.19 
120611.64 
125582.90 
158142.95 
190459.98 
207056.05 
 
50.41 
56.93 
59.28 
74.65 
89.91 
97.74 
 
  84 
in KsgA, which represent three of the six conserved C-terminal residues, leads to reduced 
activity by virtue of reduced binding121(O'Farrell, H. C.; Rife, J. P., unpublished results). 
This suggests that either RRK residues do not directly interact with the sheared base pairs 
of helix 44 or the mutations and distortion of the helix are insufficient to affect binding 
with RRK residues, only reducing catalysis marginally. More work is required to resolve 
between these possibilities. 
Helix 45 mutations 
            We wanted to determine whether KsgA binds directly on the helix 45 of 16S 
rRNA or if it binds the surrounding structures and helix 45 only reaches out and presents 
the target adenosines to the active site of KsgA. 
            Ofengand and group made point mutations in helix 45 and tested the reconstituted 
mutant 30S subunits for methylation by KsgA93, 124. The results, however, do not indicate 
whether the reduced methylation observed in case of some mutants (G1523A and 
C1524U) is due to the disruption of KsgA binding site on helix 45 or due to 
conformationally altered presentation of the target adenosines at the active site of KsgA. 
We wanted to make mutations which did not affect the helical conformation of helix 45. 
            Therefore, we made a pair of mutations, Add2bp and Del2bp, at the base of helix 
45 with the intention of preserving the local helical structure while significantly altering 
the position of the target adenosines relative to the bulk of the 30S subunit. In the first, 
two G:C base pairs were inserted between C1510:G1525 and G1511:C1524, whereas in 
the latter, two base pairs, C1509:G1526 and C1510:G1525, were deleted from the base of 
helix 45. These mutations, respectively, elongate or shorten the helix. The greatest 
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conservation for this part of helix 45 is the fact that there are a constant number of 
Watson-Crick base pairs. While there is some conservation of sequence, the greatest 
conservation appears to be the conserved helical structure. Therefore, adding two base 
pairs or deleting two such base pairs should not affect the conformation of target 
adenosines or the overall conformation of the helix. Also, the crystal structure of KsgA-
RNA reported by Tu et al. shows that this region is outside the KsgA binding site99, 
which means that at least the insertion of two base pairs in this region should not affect 
the binding of KsgA on helix 45, should it truly bind as reported by the authors of this 
study. On the other hand, if KsgA binds in such a way as to include direct interactions 
with helix 44 and the 790 loop, then helix 45 must reach out into the active site of KsgA. 
Therefore, helix 45 with two additional base pairs added might be too long to properly fit 
into the active site of KsgA. Conversely, a helix with two base pairs removed might be 
too short for the target adenosines to be able to reach it. In either case, the target 
adenosines would not be in proper position for efficient methylation. We also made one 
other mutant, DelHel45, in which the entire helix 45 was deleted, hoping to determine if 
KsgA can bind 16S rRNA in the absence of helix 45.  
            Like for the previous mutants, we examined the structural integrity of affinity 
purified, mutant subunits by running them on 10-30 % sucrose density gradients prepared 
in low magnesium buffer (Figure 28A-C). Unfortunately, the Del2bp and DelHel45 
mutants did not form any detectable 30S subunits. The Add2bp mutant did produce a 
peak at the expected position; however, a 50S subunit admixture was also observed 
(Figure 28B). 2D gel electrophoresis analysis of the Add2bp mutant subunits revealed  
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Figure 28.  Sucrose gradient analysis of Del2bp (A), Add2bp (B) and DelHel45 (C) 
mutant 30S subunits. Del2bp and DelHel45 did not form any detectable 30S. The sharp 
peak on right, in case of Add2bp, was confirmed by 2D gel electrophoresis as 50S 
contamination (data not shown). (D) Time course activity assay of affinity purified, non-
sucrose gradient, Add2bp 30S subunits. The reactions contained 200nM KsgA, 200nM 
subunits and 0.02 mM, 780cpm/pmol 3H-methyl-SAM. Assays were performed in 
triplicate; error bars represent standard deviation. CPM stands for Counts per Minute. 
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Figure 29. Two-dimensional gel electrophoresis analysis. Ribosomal proteins extracted 
from 30S subunits of MRE600R isolated by sucrose gradient (A), affinity purified 30S 
subunits of Tag-WT (B), affinity purified mutant 30S subunits of Add2bp (C), 50S 
subunits of Tag-WT isolated by sucrose gradient (D). The indicated region of (C) shows 
additional protein spots comparable to those in (D), indicating that the 30S of Add2bp 
were contaminated with 50S subunits.  
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Figure 30. HPLC trace of Add2bp mutant at the end of a 2 h reaction. The top and 
bottom traces are as described in Figure 24. 
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Table 4.  Extent of methylation of wild type and Add2bp mutant 30S subunits by KsgA 
at the end of a 2 h reaction. Normalized percent is the ratio of mutant to wild type area 
under peak/nmol x 100.  
* Area under the dimethyladenosine scintillation peak. 
Mutation Conc. of sample (nmol/80 µl) 
Area under 
the peak* 
Arear under 
peak/nmol 
Normalized 
percent (%) 
Tag-WT 15.36 3253763 211833.52 100 
Add2bp 13.28 398633 30017.54 14.17 
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that the second peak appeared due to the presence of 50S subunit impurity (Figure 29). 
Previous work by us confirmed that under the salt conditions used, even stoichiometric 
amounts of 50S have no deleterious effect on methylation. Therefore, the Add2bp mutant 
was used without further purification for qualitative analysis. A time course assay (Figure 
28D) revealed very low levels of activity, which was confirmed by HPLC (Figure 30) 
and the presence of m62A.  No m6A was observed, indicating that tight binding between 
KsgA and this mutant 30S particle remained.  Certainly, a more complete picture would 
have emerged had the Del2bp and the DelHel45 mutations produced fully formed 30S-
like particles. Nevertheless, these results with Add2bp support our proximity model, 
whereby KsgA remains anchored to helix 44/790 loop and awaits the presentation of the 
target adenosines in the loop of helix 45.       
           Considering the position of helix 45 in the structure of E. coli 30S subunit18, if 
KsgA were to bind on helix 45, it would require the enzyme to be fairly embedded in the 
16S rRNA and a corresponding large alteration of 16S conformation, something not seen 
in chemical protection experiments91. Although it has been indicated that A1518 and 
A1519 are more exposed to the solvent in the inactive state than in the active state100, this 
shift cannot be so drastic as to allow KsgA to bind helix 45 without facing spatial clashes 
with the surrounding rRNA. Also, in this case, KsgA will have to significantly disrupt the 
tertiary structure of the region in an attempt to detach after completion of methylation. 
This seems highly improbable, especially since KsgA release has been thought to bring 
about the final maturation and passage of the 30S subunits into the translation cycle69. 
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Additional mutations 
We have made several other mutations in the 16S rRNA of E. coli than those discussed 
above. However, the purification of these mutants over the GST Trap column was 
problematic, and the 30S stocks were found to be severely contaminated with 50S 
subunits. The Rife lab will continue to work on obtaining pure 30S subunits for these 
mutants and analyzing them for KsgA activity. Here, I list the mutants and the rationale 
behind creating them. 
1) AddA: KsgA transfers a total of four methyl groups from four SAM molecules to two 
adenosines, A1518 and A1519. However, the exact mechanism of the transfer remains to 
be established. Cunningham et al. reported that mutation of either adenosine does not 
disrupt dimethylation of the other, ruling out any obligate order of methylation93. We 
asked if KsgA simply scans its target site and adds as many methyl groups as possible, or 
if it is specific for transferring four methyl groups to two adenosines. To test this, we 
inserted an additional adenosine between the target nucleotides, A1518 and A1519.  
2) G1523A and C1524U: Formenoy et al. tested the importance of the highly conserved 
U1512•G1523 base pair and surrounding residues as recognition element for KsgA and 
observed an 80% reduction in methylation when G1523 was mutated to A or when 
C1524 was mutated to U124. However, they used 30S subunits reconstituted using TP30 
and in vitro transcribed 16S rRNA for their experiments. We want to determine if their 
results can be reproduced using in vivo derived mutant 30S subunits, and compare the 
efficiency of the reconstitution system with that of the in vivo derivation system. 
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3) G926 and A1394 mutants: The inactive state of the 30S subunit is not a mere 
loosening or unfolding of its active conformation. Moazed et al. described the inactive 
state as a structurally different state where some bases become more exposed to the 
solvent while some others become more sequestered111. Among the sites reported by the 
group to undergo an increase in chemical reactivity when changed from active to inactive 
state are the 923 to 927 and 1391 to 1401 intervals. In the tRNA binding studies carried 
out by Ericson et al., the delG926 mutation seemed to lock the e30S subunit in the 
inactive state, where as the A1394 mutations seemed to lock it in the active state125. We 
believe that these phenomena occur due to depletion of the Mg+2 cation that interacts with 
both, G926 and A1394 in the active state. According to the structure of E. coli 30S 
subunit18, the distance between G926 or A1394 and the KsgA target site is so great that a 
direct interaction of KsgA with these nucleotides seems unlikely. We have created 
mutations of G926 and A1394 to determine how KsgA activity is dependent upon Mg+2 
concentration and the 30S conformation. 
Conclusions 
The presence and function of KsgA has been conserved throughout evolution. It is 
anticipated that the binding site of this universally conserved enzyme on 30S subunit will 
also be conserved. We carried out a preliminary examination of some of the 16S rRNA 
sites implicated in KsgA binding. Our results indicate that G791 of the 790 loop, and to 
some extent, the sheared base pairs of helix 44 are important for the catalytic activity of 
KsgA. KsgA failed to indicate any direct interactions with helix 45 in our experiments. 
Therefore, it appears that helix 45 is not involved in binding to KsgA; rather it only 
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presents the target adenosines in its loop at the active site of KsgA. These observations 
support the proximity model, previously reported by Xu et al.91  
Experimental 
Bacterial strains and plasmids 
The bacterial strains used in this study were E. coli MRE600, DH5α (Invitrogen) 
and BL21-DE3 (Invitrogen). Recombinant KsgA was obtained as described by O'Farrell 
et al.109.  
The plasmid pGSTMS2 (gift from Prof. Rachel Green, Johns Hopkins University) 
expresses the GST-MS2 fusion protein in large quantities. This plasmid was transformed 
into BL21-DE3 cells. Growth and induction were carried out according to Youngman and 
Green120. 
The plasmids pSpurMS2 and pCI1857 were also a generous gift from Prof. Green. 
pSpurMS2 had been constructed by inserting MS2 tag in the E. coli rrnC operon of the 
plasmid pLK35. The rrnC operon is under the control of the lambda operator/promoter 
and this promoter system allows inducible expression of tagged ribosomes126. Mutations 
Del790loop, G791A, G791C, G791U, A1418C, A1483C, Add2bp (adding two G-C base 
pairs in helix 45), Del2bp (deleting two G-C base pairs in helix 45) and DelHel45 were 
introduced into the 16S rRNA gene of the pSpurMS2 rrnC operon by sited directed 
mutagenesis (Quickchange XL, Stratagene and Phusion, Finnzymes). The sequences of 
the primers used to create the mutations are listed in Table 5 (see Appendix). Primer 
information is given in appendix. The sequences of all clones were confirmed by 
sequencing at Nucleic Acids Research Facilities, Virginia Commonwealth University. 
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 The Dh5α cells were first transformed with pcI857, which contains the 
temperature-sensitive cI857 allele of the λ repressor gene. The λ cI857 repressor 
completely represses transcription from rrnC of pSpurMS2 at 30 °C, but is inactivated at 
42 °C allowing transcription from rrnC127. To obtain 30S subunits unmethylated at 
A1518 and A 1519, a standard procedure of selecting for strains resistant (>600 ug/ml) to 
the antibiotic kasugamycin was followed110. One such resistant strain (DH5αR + pcI) was 
then used to obtain untagged 30S or was transformed with wild type or mutant pSpurMS2 
to obtain wild type or mutant MS2 tagged 30S, respectively. 
Purification of His-tagged KsgA 
KsgA was purified on a HiTrap Chelating column (Amersham Pharmacia) as 
previously described in Chapter 2. Purity was assessed by SDS-PAGE. Purified protein 
was dialyzed into storage buffer containing 50mM Tris, pH 7.4, 400mM NH4Cl, 6mM 
BME and 10% glycerol. Concentration was estimated using Bradford method. Protein 
was stored at 4 °C. 
Purification of GST-MS2 fusion protein 
GST-MS2 fusion protein was purified as previously described120. Briefly, the 
clarified cell lysate from two liters induced culture was mixed with 10ml Glutathione–
Sepharose resin (Amersham Biosciences) pre-equilibrated in 1x PBS (140mM NaCl, 
2.7mM KCl, 10.2mM Na2HPO, and 1.8mM KH2PO4) and stirred at room temperature for 
30min. The mixture was then loaded onto an empty gravity flow column and the settled 
column was washed with 100ml 1x PBS. GST-MS2 protein was eluted with 40ml elution 
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buffer (50mM Tris–HCl pH 8.0, 10mM reduced glutathione), dialyzed against three 1-L 
changes of storage buffer (1x PBS, 20% glycerol) and stored at –80 °C.  
Purification of submethylated 30S ribosomal subunits 
Control untagged ribosomes were obtained from strain MRE600 and DH5αR + 
pCI via ultracentrifugation across a sucrose gradient using standard techniques111. 
In order to obtain pure, in vivo-derived mutant 30S ribosomal subunits for our 
assays, we used the MS2 affinity purification system developed by Youngman and 
Green120. In this approach, the 16S rRNA of mutant 30S is expressed from a plasmid 
borne operon in the background of wild-type ribosomes. Since mutant 30S subunits are 
assembled in vivo, they do not suffer from severe functional limitations that are 
encountered with in vitro reconstituted subunits.  
Briefly, saturated cultures of DH5α cells carrying the plasmids pcI857 and 
pSpurMS2, grown at 30 °C with amp (100ug/ml), kan (100ug/ml) and ksg ( 400 ug/ml), 
were diluted 50-fold into LB with  amp (100 ug/ml) and grown to OD600 ~0.7-0.8 at 42 
°C, to express tagged ribosomes. To obtain purified tagged 30S subunits, a 5 ml GSTrap 
FF FPLC column (Amersham Biosciences) was used. Per 70 mg crude ribosomes, 3mg 
GST-MS2 was loaded onto the column and washed with 10 ml binding buffer (20 mM 
Tris-HCl [pH 7.5], 100 mM NH4Cl, 0.3 mM MgCl2, 6mM BME). Crude ribosomes were 
then applied to the column, washed with 40 ml binding buffer and eluted with 20 ml 
elution buffer (50mM Tris-HCl [pH 7.5], 100mM NH4Cl, 0.3mM MgCl2, 10mM reduced 
glutathione, 6mM BME). Low Mg+2 concentration (0.3 mM) of the binding and elution 
buffers enable the 70S subunits to separate into constituent subunits111, allowing selective 
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retention of mutant 30S on the column. Eluted 30S subunits were dialyzed into buffer K 
(40mM Tris-HCl [pH 7.4], 40mM NH4Cl, 4mM MgOAc, 6mM BME) and  concentrated 
to at least 1nmol/ml  based on 1 A260 = 67 pmol in an Amicon Ultra centrifugal filter 
(Millipore, MWCO 100,000) and stored at –80 °C. Alternatively, to assess their structural 
integrity, eluted 30S subunits were dialyzed into a low magnesium buffer (50mM Tris–
HCl, [pH 7.5], 150mM NH4Cl, 0.3 mM MgCl2, and 6mM BME) and loaded on 10–30% 
sucrose density gradients prepared in the same buffer. The fractions containing 30S 
subunits were pooled, dialyzed against buffer K and stored at –80 °C to be used later for 
in vitro assays.  
In vitro activity assay of KsgA 
The in vitro assays were carried out according to O'Farrell et al.62. Reactions 
contained 40 mMTris (pH 7.4), 40 mM NH4Cl, 4 mM MgOAc, 6 mM BME, 0.02 mM 
3H-methyl-SAM (780 cpm/pmol; MP Biomedicals), 200 nM 30S subunits (10 pmol/50µl 
reaction), and 200 nM enzyme (10 pmol/50 µl reaction). Total reaction volume and 
components were adjusted based on the number of time points intended. To minimize any 
lag in the reaction start, buffer and reagents were prewarmed to 37 °C. At each 
designated time point, 50 µl was withdrawn and added to a prechilled tube containing 10 
µl of 100 mM unlabeled SAM (Sigma-Aldrich) to quench the reaction. The quenched 
reactions were deposited onto DE81 filter paper (Whatman), washed twice with ice-cold 
5% TCA, and rinsed briefly with ethanol. Filters were air-dried for 1 h, placed into 
scintillation fluid, and counted. Alternatively, at each designated time point, 50 µl was 
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removed and added to prechilled phenol/chloroform/isoamyl alcohol mixture to begin 
extraction of 16S rRNA for HPLC analysis (see below).  
HPLC analysis 
Labeled 16S rRNA was extracted from 30S subunits and separated on HPLC 
system as described in Chapter 3. Each sample was spiked with non-labeled N6-
methyladenosine and N6, N6-dimethyladenosine (Sigma-Aldrich) nucleoside standard for 
the ease of identification in UV chromatogram. Prior to separation, concentration of total 
nucleosides in each sample was determined by UV spectroscopy. For each sample, 80 µl 
was loaded onto the column. The values of area under the dimethyladenosine scintillation 
peak per nmol were normalized to those of wild type.  
Two dimensional gel electrophoresis analysis 
Total ribosomal proteins were extracted from ribosomes using the acetic acid 
method previously described by Siegmann & Thomas128. Briefly, 200 pmol purified 30S 
or 50S subunits stored in Buffer K (40 mMTris (pH 7.4), 40 mM NH4Cl, 4 mM MgOAc, 
6 mM BME) were ethanol precipitated in the presence of 300mM sodium acetate. The 
pellet was resuspended in 50µl dH2O and stirred together with 100µl Mg-acetate/acetic 
acid (1ml 1M magnesium acetate and 20 ml acetic acid) at 4°C. The mixture was 
centrifuged (15,000g, 30 min, 4 °C) to remove rRNAs. The supernatant containing the 
proteins was mixed with 5 volumes of acetone and allowed to precipitate overnight at 
−20 °C. Proteins were pelleted by centrifugation, resuspended in the sample buffer and 
subjected to two-dimensional gel electrophoretic analysis using the method developed by 
Geyl et al.129. The proteins were separated according to charge (pI) by isoelectric 
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focusing in the first dimension and according to size by SDS-PAGE in the second 
dimension followed by Coomassie staining of the gels for visualization. 
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CHAPTER 5: Future Work 
 
 
 
Ribosome biogenesis is a fundamental cellular process that has grown more and 
more divergent and intricate through evolution. The structural and functional 
conservation of KsgA/Dim1 enzymes through all domains of life underscores the 
importance of this family of methyltransferase and warrants the need to study them. The 
work presented here contributes significantly to the characterization of KsgA and lays a 
foundation for future work. Several questions remain to be answered to achieve the 
ultimate goal of fully defining the role of KsgA/Dim1 in ribosome biogenesis and 
applying that knowledge in the design of novel, more selective antimicrobial agents. The 
three foremost questions are: Where does KsgA bind on the 30S subunit? What is the true 
in vivo substrate for methylation by KsgA? What is the exact mechanism of methyl 
transfer? 
Our experiments have shown that G791 of helix 24 is important for KsgA 
catalysis. There were, however, no indications that KsgA interacts directly with helix 45 
or the tandem sheared base pairs of helix 44. It is extremely important to determine the 
binding site of KsgA on the 30S subunit in order to gain complete insight into the role of 
KsgA in ribosome biogenesis and how it interacts with other ribosome biogenesis factors 
or chaperons. The attempts of crystallizing 30S subunit in complex with KsgA have 
turned out to be unsuccessful. However, the Rife lab is currently employing the cryo 
  100 
electron microscopy technique to pursue the structure of this complex which, if 
successful, will tell us where KsgA binds on 30S. If not, the interaction of KsgA with 
helix 44 alone can be characterized by X-ray crystallography or NMR (Xu et al. showed 
that helix 44 is the major 16S rRNA component in binding to KsgA91).  
We have shown that KsgA binds to naked 16S rRNA but does not methylate 21S 
particle in vitro, even though it has all the eight ribosomal proteins reported by 
Thammana and Held as absolutely essential for KsgA activity96. This implies that KsgA 
recognizes an assembly state that comes after 21S has been formed. To identify the 
minimal substrate, the activated counterpart 26S can be formed in vitro and tested for 
KsgA activity. If this particle does not prove to be a substrate, then testing of more 
complicated particles may be required. Such particles can be formed by batch, single 
omission or single addition of the 26S binding ribosomal proteins (S2, S3, S10, S14, S21) 
to 26S particles. Since these proteins have also been reported to be inhibitory to 
methylation by KsgA96, such experiments will also allow us to learn whether the original 
inhibition observed with this set of proteins was accurate or was due to some impurity. In 
vivo methods can also be applied to study the minimal substrate of KsgA. One such 
approach, which will allow direct monitoring of 16S rRNA methylation events, involves 
pulse labeling of methylated RNA using 3H-methionine. The level of methylation at 
A1518/A1519 can then be determined in specific populations of 16S rRNA-containing 
ribonucleoprotein particles (RNPs) using HPLC nucleoside analysis. Additionally, to 
determine whether or not the inactive conformation of 30S exists in vivo, the in vivo 
methylation of G926 and A1394 mutant 30S can be assessed by HPLC nucleoside 
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analysis. In vitro, these mutations have been shown to trap 30S subunits in the inactive or 
active state, respectively125.  
Another outstanding question is the exact mechanism of methyl transfer. There 
are no data concerning the number of binding events required to transfer four methyl 
groups or the order in which the methyl groups are transferred by KsgA. Kinetic studies 
of wild-type and mutant KsgA proteins can help probe KsgA’s mechanism. Techniques 
such as in vitro time course analysis, HPLC nucleoside analysis and primer extension can 
be used in combination to determine the order of methyl group transfer. Also, analyzing 
the type and extent of methylation in the 30S mutant, AddA (described in Chapter 4), 
may shed some light on whether or not KsgA specifically transfers four methyl groups to 
the two adenosines. 
Connolly et al. recently showed that the E66A mutant, a methyltransferase-
inactive form of KsgA, profoundly impairs ribosome biogenesis and is deleterious to cell 
growth69. Their findings highlight the importance of methylation in KsgA function and 
ribosome biogenesis, but contrasts dramatically with the results for catalytically inactive 
Dim1p, where no phenotype is observed76. We have shown that KsgA proteins from 
distinct evolutionary kingdoms can function in a bacterial system, demonstrating 
conservation of both, the protein and the key structures of 30S subunit. However, 
Pulicherla et al. recently showed that neither the bacterial nor the archaeal ortholog could 
complement for the eukaryotic Dim177. The above discussion clearly indicates that KsgA 
has the potential of being exploited as a selective antibacterial drug target. Future work is 
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required to identify those determinants which distinguish KsgA from its orthologs. 
Preliminary efforts for KsgA inhibitor design are already underway in the Rife lab. 
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Table 5. Sequence of primers used to create mutant 16S rRNA 
 
 Primers 
1 
For 
Rev 
G791A 
5’- GGAGCAAACAGGATTAAATACCCTGGTAGTCC - 3’ 
5’- GGACTACCAGGGTATTTAATCCTGTTTGCTCC - 3’ 
2 
For 
Rev 
G791C 
5’- GGAGCAAACAGGATTACATACCCTGGTAGTCC - 3’ 
5’ - GGACTACCAGGGTATGTAATCCTGTTTGCTCC - 3’ 
3 
For 
Rev 
G791U 
5’ - GGAGCAAACAGGATTATATACCCTGGTAGTCC - 3’ 
5’ - GGACTACCAGGGTATATAATCCTGTTTGCTCC - 3’ 
4 
For 
Rev 
Del790loop 
5’ - CGTGGGGAGCAAACAGAAATGGTAGTCCACGCCG - 3’ 
5’ - CGGCGTGGACTACCATTTCTGTTTGCTCCCCACG - 3’ 
5 
For 
Rev 
A1418C 
5’ - CCGTCACACCATGGGCGTGGGTTGCAAAAGAAG - 3’ 
5’ - CTTCTTTTGCAACCCACGCCCATGGTGTGACGG - 3’ 
6 
For 
Rev 
A1483C 
5’ - CCACTTTGTGATTCATGCCTGGGGTGAAGTCG - 3’ 
5’ - CGACTTCACCCCAGGCATGAATCACAAAGTGG - 3’ 
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7 
For 
 
Rev 
 
 
DelHel45 
5’ - GCTTACCACTTTGTGATTCATGATCACCTCCTTACCTTAAA 
GAAGC - 3’ 
 
5’ - GCTTCTTTAAGGTAAGGAGGTGATCATGAATCACAAAGTGG 
TAAGC - 3’ 
8 
For 
Rev 
Del2bp 
5’ - CGTAACAAGGTAAGTAGGGGAACCTGCTTGGATCACCTCC - 3’ 
5’ - GGAGGTGATCCAAGCAGGTTCCCCTACTTACCTTGTTACG - 3’ 
 
9 
For 
 
 
Rev 
 
Add2bp (used pSpurMS2 with DelHel45 mutation as template) 
5’ - GCTTACCACTTTGTGATTCATGACTGGGGTGAAGTCGTAACAA 
GGTAACCGCGTAGGGGAACCTGCGCGGTTGGATCACCTCCTTACC 
TTAAAGAAGC - 3’ 
 
5’ - GCTTCTTTAAGGTAAGGAGGTGATCCAACCGCGCAGGTTCCCC 
TACGCGGTTACCTTGTTACGACTTCACCCCAGTCATGAATCACAAA 
GTGGTAAGC - 3’ 
 
 
10 
For 
 
 
Rev 
 
AddA (used pSpurMS2 with DelHel45 mutation as template) 
5' -  GCTTACCACTTTGTGATTCATGACTGGGGTGAAGTCGTAACAA 
GGTAACCGTAGGGGAAACCTGCGGTTGGATCACCTCCTTACCTTAA 
AGAAGC - 3'   
 
5' -  GCTTCTTTAAGGTAAGGAGGTGATCCAACCGCAGGTTTCCCCT 
ACGGTTACCTTGTTACGACTTCACCCCAGTCATGAATCACAAAGTG 
GTAAGC - 3'   
 
11 
For 
Rev 
G926A 
5' - GAATTGACGAGGGCCCGCACAAGC - 3'   
5' - GCTTGTGCGGGCCCTCGTCAATTC - 3'   
12 
For 
Rev 
G926C 
5' - GAATTGACGCGGGCCCGCACAAGC - 3'   
5' - GCTTGTGCGGGCCCGCGTCAATTC - 3'   
  117 
13 
For 
Rev 
G926U 
5' - GAATTGACGTGGGCCCGCACAAGC - 3'   
5' - GCTTGTGCGGGCCCACGTCAATTC - 3'   
14 
For 
Rev 
A1394C 
5' - CCGGGCCTTGTCCACACCGCCCG - 3'   
5' - CGGGCGGTGTGGACAAGGCCCGG - 3'   
15 
For 
Rev 
 
A1394G 
5' -  CCGGGCCTTGTGCACACCGCCCG  - 3'   
5' - CGGGCGGTGTGCACAAGGCCCGG  - 3'   
16 
For 
Rev 
A1394U 
5' - CCGGGCCTTGTTCACACCGCCCG - 3'   
5' - CGGGCGGTGTGAACAAGGCCCGG - 3'   
17 
For 
Rev 
G1523A 
5' - GGGGAACCTACGGTTGGATCACC - 3'   
5' - GGTGATCCAACCGTAGGTTCCCC - 3'   
18 
For 
Rev 
C1524U 
5' - GGGGAACCTGTGGTTGGATCACC - 3'   
5' - GGTGATCCAACCACAGGTTCCCC - 3'   
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